KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
Kol currículo para Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: Influência estatística
Relatório de execução
| Concept | World rank |
|---|---|
| girls late onset | #1 |
| farm rural children | #1 |
| foxp3 demethylation tregs | #1 |
| predictive models incidence | #1 |
| 95 nonatopic asthma | #1 |
| wheezing atopic sensitization | #1 |
| normal censored | #1 |
| gel variations gels | #1 |
| sensitisation early | #1 |
| protection asthma | #1 |
| exposure protective | #1 |
| infants karelia | #1 |
| associations airwayrelated symptoms | #1 |
| asthma aor | #1 |
| interaction npsr1 polymorphisms | #1 |
| menarche hormonal contraceptives | #1 |
| allergies respiratory infections | #1 |
| dampness childhood | #1 |
| personal cleanliness risk | #1 |
| analysis step package | #1 |
| 95 late introduction | #1 |
| homes farm dwellings | #1 |
| microbes epigenetic mechanisms | #1 |
| anthroposophic lifestyle features | #1 |
| 5–13‐year school children | #1 |
| common infections infants | #1 |
| farm asthma | #1 |
| consumption asthma | #1 |
| physiciandiagnosed asthma groups | #1 |
| domestic cats child | #1 |
| farm exposure asthmatics | #1 |
| children acrossolar cohort | #1 |
| treg marker genes | #1 |
| agreement spts | #1 |
| microbial exposure sum | #1 |
| food items year | #1 |
| incident wheezing asthma | #1 |
| exposure mattress dust | #1 |
| germany breast feeding | #1 |
| maternal farming activities | #1 |
| w12 ddhay fever | #1 |
| tnc asthma | #1 |
| edta tubes countries | #1 |
| doctor allergic rhinitis | #1 |
| annual concentrations benzene | #1 |
| employment new onset | #1 |
| food diversity year | #1 |
| wheeze environmental determinants | #1 |
| allergoprotective capacity | #1 |
| alpine farm environments | #1 |
| allergen exposure associations | #1 |
| copd sod3 | #1 |
| asthma questionnaire responses | #1 |
| age increased diversity | #1 |
| wheezerelated latent classes | #1 |
| male saline solution | #1 |
| association ilt4 | #1 |
| lower prevalence asthma | #1 |
| mite exposure risk | #1 |
| exposure muramic | #1 |
| farm environments farms | #1 |
| risk mite sensitization | #1 |
| inhaled steroids dresden | #1 |
| asthma indoor exposure | #1 |
| munich leipzig | #1 |
| epidemiologic phenotypes | #1 |
| newonset allergic rhinitis | #1 |
| protective 6 years | #1 |
| 585883 | #1 |
| lower atopy asthma | #1 |
| groups rural areas | #1 |
| bmi allergic dermatitis | #1 |
| netcomi network | #1 |
| regression approach order | #1 |
| yogurt year | #1 |
| allergy prevention studies | #1 |
| east germany allergic | #1 |
| mrna expression year | #1 |
| farm milk | #1 |
| class pasture | #1 |
| immune receptors birth | #1 |
| turkish children asthma | #1 |
| newborn interleukin17 leukocytes | #1 |
| bactoscan | #1 |
| farm living symptoms | #1 |
| 1133 children | #1 |
| participants solar | #1 |
| children diabimmune study | #1 |
| rora snps | #1 |
| age asthma child | #1 |
| farm allergic rhinitis | #1 |
| isolated cd4cd25hi tregs | #1 |
| bronchial hyperreactivity childhood | #1 |
| acrossolar | #1 |
| interaction npsr1 protein | #1 |
| data fetal growth | #1 |
| rnastabilizing solution | #1 |
| anthropometric data overweight | #1 |
| contact farm | #1 |
| germany dresden | #1 |
| ilcs inception | #1 |
| generations birth cohort | #1 |
| animal contact infancy | #1 |
| prehireonset | #1 |
| solar 2nd followup | #1 |
| farm living | #1 |
| farming allergies | #1 |
| 95 puberty | #1 |
| 95 atopic eczema | #1 |
| atopic sensitization development | #1 |
| repeated infections life | #1 |
| prognosis early wheeze | #1 |
| stimulation 45yearold children | #1 |
| allergies year | #1 |
| role th2 immunity | #1 |
| hlx1 polymorphisms | #1 |
| development allergies | #1 |
| countries pasture study | #1 |
| lower atopic sensitization | #1 |
| agents reduced risk | #1 |
| aetiology atopic disease | #1 |
| 624 children | #1 |
| chapter 16 epidemiology | #1 |
| observing children | #1 |
| concomitant bhr 95 | #1 |
| farm exposure igg4 | #1 |
| 048 95 95 | #1 |
| igg4 coexpression | #1 |
| bhr asthma child | #1 |
| peptidoglycan ppg birth | #1 |
| boys fever | #1 |
| mold subclinical inflammation | #1 |
| amish hutterite children | #1 |
| tregs asthmatics | #1 |
| girls mechanism | #1 |
| nct02496468 | #1 |
| diversity consumed types | #1 |
| crowding dry cough | #1 |
| infant genetic polymorphism | #1 |
| study questionnaire responses | #1 |
| 1314 newborn infants | #1 |
| logistic models npsr1 | #1 |
| innate immunity receptors | #1 |
| farming environments | #1 |
| dairy products protective | #1 |
| current asthma soot | #1 |
| followup farm living | #1 |
| usage preventive measures | #1 |
| aetiology early years | #1 |
| protective childhood | #1 |
| cowsheds cattle | #1 |
| aor interquartile range | #1 |
| 95 asthmatic children | #1 |
| th2related genes cytokines | #1 |
| perinatal influences | #1 |
| asthma bacterial diversity | #1 |
| unbalanced meat consumption | #1 |
| children road traffic | #1 |
| egg aor | #1 |
| visible mold homes | #1 |
| dzl | #1 |
| aa hcs | #1 |
| asthmatic farm children | #1 |
| shop milk | #1 |
| rural children w12 | #1 |
| provocation time | #1 |
| epigenetic regulation mechanism | #1 |
| dermatitis depending | #1 |
| igein | #1 |
| protective factors strategies | #1 |
| east germany leipzig | #1 |
| yogurt diversity | #1 |
| asthma microbiome analysis | #1 |
| insight asthma | #1 |
| igg1 galactosylation levels | #1 |
| overweight marked differences | #1 |
| allergic diseases hrqol | #1 |
| allergic allergic dermatitis | #1 |
| incidence indoor allergens | #1 |
| atopy allergen specificity | #1 |
| living environment children | #1 |
| 17q21 locus method | #1 |
| asthma 105 years | #1 |
| solids development | #1 |
| pasture lukas2 | #1 |
| bronchial hyperreactivity age | #1 |
| farmers nonfarmers children | #1 |
| dairying environment pollen | #1 |
| allergic asthmatics asthmatics | #1 |
| farming environments asthma | #1 |
| lca feeding patterns | #1 |
| treatment 9 bronchodilators | #1 |
| anti‐asthmatic drugs | #1 |
| regular farm animal | #1 |
| allergies cohort studies | #1 |
| histamine challenges age | #1 |
| positive sensitization | #1 |
| farm indoor | #1 |
| childhood asthma age | #1 |
| asthma dresden | #1 |
| managing wheezing | #1 |
| risk tcell phenotypes | #1 |
| peak airborne moulds | #1 |
| barns samples | #1 |
| unpasteurized cows milk | #1 |
| regular farm | #1 |
| actinomycetes peak | #1 |
| allergic rhinitis jia | #1 |
| influential factors phenotype | #1 |
| asthma concomitant asthma | #1 |
| farmers children | #1 |
| parasitic infections predictor | #1 |
| preschool children predictor | #1 |
| life inversely | #1 |
| farm lung function | #1 |
| fever blood samples | #1 |
| maternal farm exposure | #1 |
| protective effects exposure | #1 |
| children isaac asthma | #1 |
| il13cd4 cells ilcs | #1 |
| traditional farms | #1 |
| sod3 sod3 snps | #1 |
| muramic acid wheezing | #1 |
| overweight munich | #1 |
| infant adolescent aging | #1 |
| unprocessed cows milk | #1 |
| latent classes populations | #1 |
| male parents receptors | #1 |
| microbial exposure asthma | #1 |
| unremitting wheeze | #1 |
| barns farm dwellings | #1 |
| single microbial markers | #1 |
| antipyretics increased risk | #1 |
| tregs cd4cd25hi | #1 |
| maternal farm | #1 |
| adolescent aging asthma | #1 |
| children farmers | #1 |
| provocation time bhr | #1 |
| work ilc2s | #1 |
| protective effects diversity | #1 |
| allergy‐protective effects | #1 |
| rora neuropeptide receptor | #1 |
| early phenotypes age | #1 |
| phytohemagglutinin ormdl3 | #1 |
| antiasthma drugs children | #1 |
| allergic germany | #1 |
| phase isaac programme | #1 |
| bronchial hyperreactivity wheezing | #1 |
| allergies viral infections | #1 |
| protective allergic diseases | #1 |
| lumbricoides farmers children | #1 |
| atopic sensitisation fever | #1 |
| allergic rhinitis predictor | #1 |
| farm reduced prevalence | #1 |
| munich dresden | #1 |
| asthma concomitant bhr | #1 |
| microorganisms animal sheds | #1 |
| atopic dermatitis jobs | #1 |
| maternal atopy tregs | #1 |
| allergy symptoms childhood | #1 |
| west germany overweight | #1 |
| asthma risk pasture | #1 |
| children preschool conjunctivitis | #1 |
| tbx21 | #1 |
| life chronic asthma | #1 |
| ml1 cohort studies | #1 |
| treatment childhood asthma | #1 |
| sige cutoff | #1 |
| protective atopic sensitization | #1 |
| dampness bronchial hyperreactivity | #1 |
| review hygiene hypothesis | #1 |
| incident wheezing women | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| predominant obstruction | #1 |
| cd4cd25hi isolated cells | #1 |
| regulatory responses protection | #1 |
| validity food questionnaire | #1 |
| asthma bronchial response | #1 |
| increased risks rhinoconjunctivitis | #1 |
| th2 th1 gsdma | #1 |
| str bhr | #1 |
| ige levels exposure | #1 |
| development asthma | #1 |
| school age early | #1 |
| allergies addition | #1 |
| farm farm children | #1 |
| allergen exposure age | #1 |
| farm nonfarm children | #1 |
| asthma genetic effects | #1 |
| factors th1 | #1 |
| school children germany | #1 |
| phenotypes atopic | #1 |
| endotoxin level production | #1 |
| covariates potential confounding | #1 |
| farm animals cats | #1 |
| wheezing children wheezing | #1 |
| throat microbiota | #1 |
| farming protective farm | #1 |
| asthma wisc | #1 |
| complementary food year | #1 |
| allergoprotective | #1 |
| increased risk rhinoconjunctivitis | #1 |
| 812 children | #1 |
| wheeze asthma questions | #1 |
| mite sensitization aor | #1 |
| symptoms gender ratio | #1 |
| yogurt cows milk | #1 |
| atopy interactions | #1 |
| farming nasal samples | #1 |
| allergy protective | #1 |
| polymorphisms lps recognition | #1 |
| spt atopic dermatitis | #1 |
| hrqol protective | #1 |
| seasonal rural | #1 |
| polysaccharides cde | #1 |
| tenascin neuropeptide receptor | #1 |
| children early phenotypes | #1 |
| h4 acetylation offspring | #1 |
| factor school behavior | #1 |
| grass arabinogalactan mice | #1 |
| hygiene hypothesis endotoxin | #1 |
| expiratory volume lca | #1 |
| pierced ears asthma | #1 |
| atopic embryonic | #1 |
| genetic interaction npsr1 | #1 |
| asthma risk lca | #1 |
| tnc risk gene | #1 |
| aa clec4e | #1 |
| paper online questionnaires | #1 |
| lukas2 lca | #1 |
| bacterial exposures | #1 |
| no2 allergic sensitisation | #1 |
| solar iii | #1 |
| supplementation milk cla | #1 |
| development allergic illnesses | #1 |
| hyperreactive children | #1 |
| tubes rnastabilizing solution | #1 |
| “atopic march | #1 |
| sige spt | #1 |
| allergic rhinitis type | #1 |
| farm milk meat | #1 |
| unhygienic contact | #1 |
| children unification | #1 |
| lpastimulation carriers | #1 |
| worldwide asthma epidemic | #1 |
| changing gender ratio | #1 |
| 95 asthma | #1 |
| sige association | #1 |
| prediction quality snps | #1 |
| increased atp2a3 fpr2 | #1 |
| prediction farm children | #1 |
| 26 farms bavaria | #1 |
| 9 10yold children | #1 |
| 17q21 polymorphisms | #1 |
| protective mechanisms asthma | #1 |
| fever spt cutoff | #1 |
| preschool wheezing aor | #1 |
| estonia environmental differences | #1 |
| 1120 children | #1 |
| diseases farm | #1 |
| children severe atopy | #1 |
| score total quantity | #1 |
| occurrence allergy | #1 |
| allergies early phenotypes | #1 |
| patients treg cells | #1 |
| followup work discontent | #1 |
| lca clinical phenotypes | #1 |
| cla allergoprotective capacity | #1 |
| farm environments asthma | #1 |
| introduction yogurt | #1 |
| farm animals childhood | #1 |
| asthma bacteria | #1 |
| 3 mm spt | #1 |
| childhood gondii seropositivity | #1 |
| rs7164773 | #1 |
| ddhay fever children | #1 |
| farming environment role | #1 |
| cε germline transcript | #1 |
| no2 traffic counts | #1 |
| europe protection | #1 |
| cla content plasma | #1 |
| ilt4 cord blood | #1 |
| determinants airway responsiveness | #1 |
| stable dust extract | #1 |
| npsr1 messenger receptors | #1 |
| protective farm environment | #1 |
| farm studies | #1 |
| lca male phenotype | #1 |
| child environmental pollutants | #1 |
| childhood asthma allergies | #1 |
| symptoms school age | #1 |
| richness asthma | #1 |
| netcomi functionality | #1 |
| 3785 adolescents | #1 |
| identified polymorphisms asthma | #1 |
| farm dairy products | #1 |
| wheezing 3rd year | #1 |
| tolllike receptor farmers | #1 |
| model hyperreactivity | #1 |
| children farm children | #1 |
| tregs life | #1 |
| rs2738751 | #1 |
| preventive measures counselling | #1 |
| ilt4 cb | #1 |
| fever atopic | #1 |
| hyperreactivity expiratory volume | #1 |
| aa increased atp2a3 | #1 |
| wheezing fever | #1 |
| transient wheeze age | #1 |
| association farm contact | #1 |
| respiratory symptoms childhood | #1 |
| study parsifal | #1 |
| environmental exposures asthma | #1 |
| wheeze farmers children | #1 |
| protective cheese consumption | #1 |
| association spink5 420lys | #1 |
| mice atopic sensitization | #1 |
| sige sensitizations symptoms | #1 |
| development atopic sensitisation | #1 |
| positive sensitization egg | #1 |
| source arabinogalactan | #1 |
| quantitative confirmation associations | #1 |
| secretion life | #1 |
| age bacterial endotoxin | #1 |
| new microscope | #1 |
| tregs maternal atopy | #1 |
| associations dna fingerprinting | #1 |
| protective farming | #1 |
| bacterial groups prevalence | #1 |
| atopic smokers baseline | #1 |
| microorganisms farms | #1 |
| fpr2 clec4e | #1 |
| dresden east germany | #1 |
| farm dwellings children | #1 |
| associations pet contact | #1 |
| wheeze farming exposure | #1 |
| subtypes atopic dermatitis | #1 |
| asthma atopic disease | #1 |
| school university life | #1 |
| 7 yrs determinants | #1 |
| dgge health outcomes | #1 |
| asthma austria allergic | #1 |
| predictor immune activation | #1 |
| ascaris lumbricoides exposure | #1 |
| asthma tregs | #1 |
| farm dwellings homes | #1 |
| predictor igg1 galactosylation | #1 |
| children leipzig | #1 |
| pets farm animals | #1 |
| early age risk | #1 |
| new onset wheeze | #1 |
| asthmaprotective farm | #1 |
| questionnaires childhood | #1 |
| wheeze classes | #1 |
| actinomycetes cowsheds | #1 |
| increased expression ormdl3 | #1 |
| males pierced ears | #1 |
| antipyretics reduced risk | #1 |
| kazal type spink5 | #1 |
| censored immunological | #1 |
| pollen dairy farms | #1 |
| tregs foxp3 demethylation | #1 |
| indoor microbiota development | #1 |
| cowshed dust cde | #1 |
| pcr sscp method | #1 |
| allergies personal cleanliness | #1 |
| transient wheezing age | #1 |
| farm animals asthma | #1 |
| predominant hyperreactivity subsample | #1 |
| solids relation | #1 |
| coupled receptor polymorphisms | #1 |
| allergies childhood phase | #1 |
| pets crowding | #1 |
| gene expression ilt3 | #1 |
| maternal atopy secretion | #1 |
| sum indicators | #1 |
| development childhood asthma | #1 |
| allergic diseases protective | #1 |
| farm exposure asthma | #1 |
| 12 months crowding | #1 |
| bhr str | #1 |
| soot benzene | #1 |
| skin tests spt | #1 |
| arabinogalactan cde | #1 |
| gsdma phytohemagglutinin | #1 |
| persistence bronchial hyperreactivity | #1 |
| asthma richness | #1 |
| stepwise protocol phase | #1 |
| methods 2nd followup | #1 |
| obstruktive atemwegserkrankungen | #1 |
| adolescence bronchial hyperreactivity | #1 |
| reduced risk allergy | #1 |
| tnc npsr1 | #1 |
| farm fever | #1 |
| age dust microbiota | #1 |
| protective exposures | #1 |
| fever farm | #1 |
| infancy case status | #1 |
| preschool children rhinitis | #1 |
| childhood design | #1 |
| recurrent unremitting wheeze | #1 |
| regulatory triggering receptor | #1 |
| juvenile crohn disease | #1 |
| rural allergy endotoxin | #1 |
| childhood asthma fever | #1 |
| pets associations | #1 |
| asthmatics innate leukocytes | #1 |
| farm wheeze phenotypes | #1 |
| countries isaac phase | #1 |
| work overload school | #1 |
| hrqol rural farm | #1 |
| asthma toll | #1 |
| cowsheds childrens bedrooms | #1 |
| protective diversity | #1 |
| isaac phase data | #1 |
| exposure farm | #1 |
| “hygiene hypothesis | #1 |
| atopic sensitization birth | #1 |
| strongest predictor atopy | #1 |
| ema protective farm | #1 |
| asthma asthma bacteria | #1 |
| study prehireonset | #1 |
| patients neutrophil inflammation | #1 |
| 30 amish | #1 |
| parsifal‐study | #1 |
| 12 months doctor | #1 |
| th2related genes | #1 |
| immune activation populations | #1 |
| hypopharynx moraxella | #1 |
| asthma turkish children | #1 |
| atopy rural subjects | #1 |
| asthmatic children result | #1 |
| cutoff 3 mm | #1 |
| animal sheds 28 | #1 |
| gsdma expression secretion | #1 |
| breastfeeding length | #1 |
| interquartile range asthma | #1 |
| endotoxin exposure association | #1 |
| hlx1 polymorphisms influence | #1 |
| 57 911yearold children | #1 |
| farmers anthroposophic families | #1 |
| identification immune phenotypes | #1 |
| network differences groups | #1 |
| kitchen visible mold | #1 |
| 5 years aor | #1 |
| farming environment development | #1 |
| agreement association | #1 |
| neonatal immune mechanisms | #1 |
| farm protects | #1 |
| overweight dresden | #1 |
| association atopic sensitization | #1 |
| grass pollen 95 | #1 |
| asthma symptoms adolescence | #1 |
| followup solar | #1 |
| asthma west germany | #1 |
| protection yogurt | #1 |
| stepwise procedure risk | #1 |
| early development wheeze | #1 |
| prevent allergic diseases | #1 |
| derp1lpa | #1 |
| food allergy yogurt | #1 |
| atopic sensitization aor | #1 |
| linens child dust | #1 |
| questionnaire responses asthma | #1 |
| muramic acid concentration | #1 |
| hyperreaktivität | #1 |
| health services exposure | #1 |
| samples farm dwellings | #1 |
| city air pollution | #1 |
| bacterial signals atopy | #1 |
| adolescents jobs | #1 |
| agriculture asthma | #1 |
| carriers hlx1 | #1 |
| asthma german | #1 |
| newborn leukocytes surveys | #1 |
| single taxa groups | #1 |
| asthma arabinogalactan | #1 |
| occupational disinfectants asthma | #1 |
| children 7 yrs | #1 |
| farm children hrqol | #1 |
| farm children microorganisms | #1 |
| prevalence environmental factors | #1 |
| protective effects asthma | #1 |
| studies microbial exposures | #1 |
| atopic diseases association | #1 |
| prehireonset odds ratio | #1 |
| specific exposures cows | #1 |
| pierced ears association | #1 |
| 420lys | #1 |
| year environmental exposures | #1 |
| atopic dermatitis onset | #1 |
| npsr1 interaction | #1 |
| farming exposure childhood | #1 |
| increased food diversity | #1 |
| atopic disease bias | #1 |
| igg4 ige expression | #1 |
| ahr acinetobacter lwoffii | #1 |
| potential confounders jobs | #1 |
| pasture cohort | #1 |
| vehicle traffic asthma | #1 |
| solar cohort | #1 |
| gabriel study | #1 |
| german peers | #1 |
| abundances 6 otus | #1 |
| farms wheeze | #1 |
| accuracy regression approach | #1 |
| wheezing male respiratory | #1 |
| multicenter cohort prevalence | #1 |
| mold immune responsiveness | #1 |
| allergen exposure life | #1 |
| classical definitions lca | #1 |
| external microbial | #1 |
| birth tbx21 | #1 |
| 911 yrs | #1 |
| domestic asthma child | #1 |
| lpa ppg stimulation | #1 |
| persistence allergic rhinitis | #1 |
| allergic rhinitis puberty | #1 |
| otus bacterial diversity | #1 |
| cleanliness matter | #1 |
| wheezing w12 | #1 |
| prenatal farm | #1 |
| comparison microbiome data | #1 |
| children predominant hyperreactivity | #1 |
| 95 agmr | #1 |
| pasture cohort lca | #1 |
| netcomi | #1 |
| maternal farming | #1 |
| asthma farm children | #1 |
| asthma turkish | #1 |
| dgge asthma | #1 |
| snps wheeze | #1 |
| increased diversity food | #1 |
| 18 months protective | #1 |
| exposure farm children | #1 |
| t1432c | #1 |
| immune stimulation life | #1 |
| seasonal allergens | #1 |
| domestic child child | #1 |
| children amish children | #1 |
| milk asthma | #1 |
| lukas2 birth cohorts | #1 |
| alpine farms | #1 |
| 95 endotoxin exposure | #1 |
| 1 ppg stimulation | #1 |
| igg nglycosylation populations | #1 |
| 95 hormonal contraceptives | #1 |
| farm homes homes | #1 |
| microbial exposure endotoxin | #1 |
| persistence adolescence | #1 |
| atopic dermatitis adolescence | #1 |
| 457 iu | #1 |
| data netcomi | #1 |
| solar study | #1 |
| 17q21 risk | #1 |
| children alliance asthma | #1 |
| ppg lpa ppg | #1 |
| 45yearold children protection | #1 |
| asthma diversity | #1 |
| higher hscrp values | #1 |
| atopic dermatitis farm | #1 |
| bamse npsr1 | #1 |
| sensitised children wheeze | #1 |
| immune responsiveness life | #1 |
| 1 year occurrence | #1 |
| fever atopic sensitization | #1 |
| prenatal animal contact | #1 |
| gsdma expression | #1 |
| tregs age | #1 |
| asthma interactions | #1 |
| stepwise procedure gene | #1 |
| traditional upbringing | #1 |
| ormdl3 gasdermin | #1 |
| personal cleanliness | #1 |
| puberty infant | #1 |
| moisture mold exposure | #1 |
| allergies | #1 |
| coexpression igg1 | #1 |
| bronchial hyperreactivity adolescence | #1 |
| heattreated milk samples | #1 |
| otitis fever | #1 |
| farm animal exposure | #1 |
| auc spt | #1 |
| rs11079788 | #1 |
| topic puberty rhinitis | #1 |
| igg1 galactosylation predictor | #1 |
| allergic rhinitis childhood | #1 |
| crude measure exposure | #1 |
| allergyprotective potential | #1 |
| bacterial exposures associations | #1 |
| feeding patterns risk | #1 |
| hc aa | #1 |
| bifidobacterium breastfed infants | #1 |
| messenger surveys | #1 |
| cough soot | #1 |
| farm cowsheds | #1 |
| environments pasture | #1 |
| allergies atopic dermatitis | #1 |
| asthma allergies | #1 |
| early life insight | #1 |
| 168fold | #1 |
| respiratory sounds immunity | #1 |
| life fungi humans | #1 |
| jobs potential confounders | #1 |
| 13 microbial influences | #1 |
| transient wheeze asthma | #1 |
| pasture study spt | #1 |
| parental questionnaires | #1 |
| relation late introduction | #1 |
| allergic rhinitis menarche | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| dermatitis symptoms | #1 |
| functionality network differences | #1 |
| nickel allergy asthma | #1 |
| lumbricoides crude measure | #1 |
| protection allergic diseases | #1 |
| endotoxin allergy | #1 |
| package functionality | #1 |
| diagnosed fever 95 | #1 |
| children rural allergy | #1 |
| environmental microbial | #1 |
| environmental exposures protection | #1 |
| antibiotics allergies | #1 |
| persistence earlylife exposures | #1 |
| pattern atopic sensitization | #1 |
| phenotype health variables | #1 |
| benzene current wheeze | #1 |
| current asthma age | #1 |
| fever atopic dermatitis | #1 |
| wheeze sensitisation | #1 |
| 105 years richness | #1 |
| associations maternal sensitization | #1 |
| rora susceptibility gene | #1 |
| prenatal animal | #1 |
| allergies topic surveys | #1 |
| repeated episodes fever | #1 |
| bronchial obstruction hyperreactivity | #1 |
| aor farm exposures | #1 |
| 6 types cheese | #1 |
| 9 bronchodilators | #1 |
| association incident rhinoconjunctivitis | #1 |
| lpastimulation cord blood | #1 |
| south bavarian | #1 |
| hlx1 snps cbmcs | #1 |
| infancy jia | #1 |
| late introduction solids | #1 |
| airborne moulds actinomycetes | #1 |
| tcells foxp3 | #1 |
| acrossolar study | #1 |
| parents allergies | #1 |
| late onset menarche | #1 |
| farmingrelated exposures | #1 |
| farming environment protective | #1 |
| atopic embryonic allergic | #1 |
| npsr1 tnc | #1 |
| analyses isaac phase | #1 |
| wheezing invertedu shape | #1 |
| cd4creil13 | #1 |
| allergy exposures | #1 |
| atopic dermatitis increase | #1 |
| cowsheds farm animals | #1 |
| jobs asthma risk | #1 |
| allergies cohort | #1 |
| neonatal mice ahr | #1 |
| health influential factors | #1 |
| environmental allergens variety | #1 |
| tobit regression ranks | #1 |
| clec4e aa | #1 |
| marked differences prevalence | #1 |
| followup solar iii | #1 |
| association occupational disinfectants | #1 |
| atopy microbial influences | #1 |
| cattle childrens bedrooms | #1 |
| increased prevalence cough | #1 |
| environmental differences finland | #1 |
| offspring atopic mothers | #1 |
| occurrence generations | #1 |
| insight environmental factors | #1 |
| higher specificity asthma | #1 |
| psychosocial characteristics asthma | #1 |
| psychosocial characteristics children | #1 |
| crobiome data | #1 |
| living area risk | #1 |
| farm childhood asthma | #1 |
| childhood dampness | #1 |
| gene expression ormdl3 | #1 |
| 95 grass pollen | #1 |
| phase international | #1 |
| 035 iu specificity | #1 |
| farming children | #1 |
| association farm | #1 |
| features anthroposophic lifestyle | #1 |
| associations hscrp values | #1 |
| rhinoconjunctivitis sex | #1 |
| work overload work | #1 |
| asthmatics hc | #1 |
| protection hygiene hypothesis | #1 |
| diversity protective effects | #1 |
| diversity microbial exposure | #1 |
| 5 years predictor | #1 |
| cd4cd25hi tcells | #1 |
| order covariates | #1 |
| richness farming | #1 |
| spink5 420lys | #1 |
| allergies existing cohort | #1 |
| transcription factors hlx1 | #1 |
| hrqol farm children | #1 |
| farm milk consumption | #1 |
| asthma symptoms adulthood | #1 |
| phenotypes lca | #1 |
| allergy cohort methods | #1 |
| polymorphisms tbx21 | #1 |
| cumulative incidence finland | #1 |
| common inhalants | #1 |
| egg positive sensitization | #1 |
| foxp3 cd4cd25hi | #1 |
| bronchial response wheeze | #1 |
| infant contact animals | #1 |
| dust parameters development | #1 |
| methods solar cohort | #1 |
| life antibiotic exposure | #1 |
| 18 95 incidence | #1 |
| authors grass arabinogalactans | #1 |
| rs11071559 | #1 |
| study rural environment | #1 |
| 2nd followup challenges | #1 |
| farm exposure exposure | #1 |
| children amish farms | #1 |
| model bronchial hyperreactivity | #1 |
| helminth parasites exposure | #1 |
| recurrence atopic dermatitis | #1 |
| amish environment | #1 |
| allergic illnesses | #1 |
| fpr2 aa | #1 |
| phase stratified sample | #1 |
| microbiome data package | #1 |
| farms farm homes | #1 |
| asthma risk class | #1 |
| unifying computational tool | #1 |
| amish hutterite | #1 |
| followup solar cohort | #1 |
| farm fungi humans | #1 |
| lps recognition development | #1 |
| cbmcs ormdl3 | #1 |
| demethylation foxp3 demethylation | #1 |
| adolescent agriculture dust | #1 |
| otus farming | #1 |
| ilcs neonatal mice | #1 |
| menarche hormonal | #1 |
| milkassociated cla | #1 |
| 95 allergen | #1 |
| 28 dust samples | #1 |
| moisture damage kitchen | #1 |
| farmrelated exposures | #1 |
| crohns disease atopy | #1 |
| girls allergic rhinitis | #1 |
| excessive sige production | #1 |
| asthma german children | #1 |
| asthmatics asthma phenotypes | #1 |
| animal farms substances | #1 |
| incident wheezing | #1 |
| protection childhood asthma | #1 |
| spts agreement | #1 |
| feeding overweight | #1 |
| humans hypopharynx moraxella | #1 |
| asthma puberty | #1 |
| bhr fall | #1 |
| indicators total quantity | #1 |
| association haplotype studies | #1 |
| non‐farm children | #1 |
| pasture study tubes | #1 |
| kitchen moisture damage | #1 |
| oropharyngeal microbiota children | #1 |
| maturation gut microbiome | #1 |
| hypersensitivity infections | #1 |
| consumption allergic | #1 |
| farm children bavaria | #1 |
| harmful workplace exposure | #1 |
| rora asthma susceptibility | #1 |
| clinical examinations challenges | #1 |
| ige seasonal allergens | #1 |
| protective farm asthma | #1 |
| feeding cattle cowsheds | #1 |
| exposure farming environment | #1 |
| endotoxin levels samples | #1 |
| unprocessed farm milk | #1 |
| living farm | #1 |
| asthma consumption | #1 |
| work overload followup | #1 |
| environmental factors sensitization | #1 |
| subsample predominant obstruction | #1 |
| animal sheds barns | #1 |
| failure☆ | #1 |
| wholeto | #1 |
| rhinoconjunctivitis participation | #1 |
| initial cohort pattern | #1 |
| wheeze active smoking | #1 |
| 20 fall volume | #1 |
| computing microbial associations | #1 |
| 5–13‐year | #1 |
| 1120 german schoolchildren | #1 |
| cord blood offspring | #1 |
| damage systemic inflammation | #1 |
| asthma protective | #1 |
| netcomi network construction | #1 |
| infections hygiene hypothesis | #1 |
| epidemiologic phenotype | #1 |
| gpra gene | #1 |
| farm milk exposure | #1 |
| menarche allergic | #1 |
| immunity innate infant | #1 |
| aa ifih1 expression | #1 |
| dresden munich | #1 |
| aa immunity receptors | #1 |
| association farm milk | #1 |
| gasdermin gsdma | #1 |
| blood ormdl3 | #1 |
| 15ans | #1 |
| swinesheds | #1 |
| ranks performance | #1 |
| microbial exposure patterns | #1 |
| grass arabinogalactan | #1 |
| tbx21 hlx1 | #1 |
| jia domestic arthritis | #1 |
| endotoxin levels stables | #1 |
| anthroposophic families validity | #1 |
| menarche allergic rhinitis | #1 |
| maschildren | #1 |
| lukas2 umc | #1 |
| evidence allergy prevention | #1 |
| children atopic sensitization | #1 |
| ilcs administration | #1 |
| indoor bacterial microbiota | #1 |
| current contact asthma | #1 |
| gabriel advanced study | #1 |
| unprocessed cow | #1 |
| allergies protective pet | #1 |
| germany allergic | #1 |
| pollen concentration feeding | #1 |
| influential factors health | #1 |
| tbx21 hlx1 snps | #1 |
| associations transient sensitization | #1 |
| atopic sensitization | #1 |
| lpastimulation | #1 |
| children beta 2agonists | #1 |
| lca pasture | #1 |
| south bavarian population | #1 |
| exposure gstm1 deficiency | #1 |
| atopy farm | #1 |
| atopic sensitization early | #1 |
| gene expression ilt4 | #1 |
| selection bias responders | #1 |
| fever milk consumption | #1 |
| risk gene asthma | #1 |
| west germany munich | #1 |
| mold problems children | #1 |
| mattress dust association | #1 |
| heating children | #1 |
| childhood bronchial hyperreactivity | #1 |
| coding region il4ra | #1 |
| farm specific exposures | #1 |
| mold problems kitchen | #1 |
| transmaternal asthma protection | #1 |
| yoghurt asthma risk | #1 |
| tempo method | #1 |
| farming asthma | #1 |
| farm lifestyles | #1 |
| protective asthma | #1 |
| alliance asthma | #1 |
| interaction rora | #1 |
| leipzig munich | #1 |
| npsr1 rora | #1 |
| kitchen living area | #1 |
| germany prevalence differences | #1 |
| stepwise protocol bhr | #1 |
| lps foxp3 demethylation | #1 |
| participation rates phase | #1 |
| asthma symptoms community | #1 |
| childhood allergy children | #1 |
| health urbanrural differences | #1 |
| paediatric origins | #1 |
| cohorte pasture | #1 |
| spts specific ige | #1 |
| development preschool wheezing | #1 |
| genetic association tnc | #1 |
| life maternal atopy | #1 |
| consumption farm milk | #1 |
| late introduction egg | #1 |
| loft farm milk | #1 |
| risk hutterite children | #1 |
| analyses provocation time | #1 |
| selfreported nickel allergy | #1 |
| infant inflammation crp | #1 |
| leur relation | #1 |
| allergic sensitization latex | #1 |
| west germany allergic | #1 |
| gpra polymorphisms asthma | #1 |
| associations indoor mould | #1 |
| il4ra association | #1 |
| children indoor mould | #1 |
| spink5 kazal type | #1 |
| cde source | #1 |
| gabriel advanced surveys | #1 |
| expression 17q21 | #1 |
| rhinitis predictor | #1 |
| ddhay fever 95 | #1 |
| allergies endotoxin | #1 |
| eczema regions | #1 |
| preschool dermatitis questionnaires | #1 |
| allergic diseases questionnaires | #1 |
| mrna expression tregs | #1 |
| 035 iu sige | #1 |
| ddhay fever | #1 |
| allergies generations | #1 |
| epidemiological evidence consumption | #1 |
| network construction netcomi | #1 |
| allergyrisk factors | #1 |
| gpra polymorphisms | #1 |
| phenotypes atopic sensitization | #1 |
| immunity newborn mothers | #1 |
| ormdl3 gsdma expression | #1 |
| children automobiles child | #1 |
| food sensitization egg | #1 |
| life protective | #1 |
| male poland quality | #1 |
| wheeze bronchial | #1 |
| farm milk asthma | #1 |
| wheeze farm living | #1 |
| allergic diseases cutoff | #1 |
| immune responses birth | #1 |
| incident wheezing association | #1 |
| environmental exposure age | #1 |
| childrens bedrooms cowsheds | #1 |
| serum ige levels | #1 |
| environments asthma | #1 |
| actinomycetes alpine farms | #1 |
| 115 iu | #1 |
| prevalence atopic sensitisation | #1 |
| crp early age | #1 |
| groups netcomi | #1 |
| 6 years subtypes | #1 |
| pet contact infancy | #1 |
| helminths protective | #1 |
| moderate‐to‐adequate | #1 |
| cleanliness dust parameters | #1 |
| exposures pieces | #1 |
| asthma food sensitization | #1 |
| 95 atopic sensitization | #1 |
| airborne fungi actinomycetes | #1 |
| infant design | #1 |
| advanced surveys | #1 |
| cowsheds peak | #1 |
| aa nonallergic asthma | #1 |
| network construction comparison | #1 |
| childhood protective | #1 |
| asthma rora | #1 |
| atopic eczema 95 | #1 |
| adolescent agriculture | #1 |
| current wheeze benzene | #1 |
| current interpretation | #2 |
| lessaffluent countries | #2 |
| exposure life | #2 |
| dairying eczema | #2 |
| consumption unprocessed | #2 |
| genetic variation card4 | #2 |
| 19th century allergic | #2 |
| farmers child cross | #2 |
| doctors diagnosis aor | #2 |
| study participants fieldworkers | #2 |
| adult farmers role | #2 |
| new onset wheezing | #2 |
| munich participants | #2 |
| bronchitis east germany | #2 |
| childhood phase | #2 |
| asthma crp | #2 |
| pha maternal farming | #2 |
| cd14 1721 | #2 |
| quartile work discontent | #2 |
| allergies cd14 expression | #2 |
| interval156 | #2 |
| animal sheds pregnancy | #2 |
| ages strongest associations | #2 |
| protect development | #2 |
| lifelong farm exposure | #2 |
| 95 protective factors | #2 |
| olive pollen dander | #2 |
| domestic child dust | #2 |
| severe exacerbations feno | #2 |
| nonfarm children | #2 |
| healthcare precision medicine | #2 |
| newonset asthma symptoms | #2 |
| participants dresden | #2 |
| associations atopy | #2 |
| farming environment mother | #2 |
| children dresden | #2 |
| alk samples fieldworkers | #2 |
| c4ma3 biomarker | #2 |
| sensitized patients order | #2 |
| microbial exposure study | #2 |
| c4ma3 asthma | #2 |
| severity spirometric measures | #2 |
| gels bands | #2 |
| wheeze bronchial responsiveness | #2 |
| eczema lessaffluent countries | #2 |
| children affluent countries | #2 |
| nonfarming mothers lipid | #2 |
| atopic eczema phenotypes | #2 |
| asthma observed | #2 |
| maternal immunity gondii | #2 |
| artemisia olive pollen | #2 |
| alliance ages | #2 |
| lipid ppg | #2 |
| arg130gln polymorphism linkage | #2 |
| fieldworkers absolute levels | #2 |
| allele specific ige | #2 |
| endotoxin allergen exposure | #2 |
| childhood obesoty | #2 |
| germany asthma | #2 |
| age allergic rhinitis | #2 |
| south bavaria | #2 |
| dander artemisia | #2 |
| ages current paracetamol | #2 |
| allergen levels socks | #2 |
| bacteriological properties | #2 |
| positive maternal record | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| sensitization patterns inhalant | #2 |
| allergic asthma degradation | #2 |
| indoor bacterial | #2 |
| human microbiota asthma | #2 |
| traditional farm | #2 |
| nocturnal symptoms spirometry | #2 |
| immunoglobulin nod1 | #2 |
| atopic sensitization 14 | #2 |
| university baseline | #2 |
| gmcsf ifnγ levels | #2 |
| bronchial challenge children | #2 |
| study participants levels | #2 |
| isaac prevalence rates | #2 |
| isaac atopic eczema | #2 |
| levels alk samples | #2 |
| exposure farmers children | #2 |
| work discontent | #2 |
| polymorphisms il13 gene | #2 |
| peptidoglycan ppg | #2 |
| specificity lca | #2 |
| tregs demethylation | #2 |
| nocturnal asthma severity | #2 |
| statistical analysis performance | #2 |
| alk samples levels | #2 |
| eczema farmers children | #2 |
| asthma symptoms children | #2 |
| atopic developing countries | #2 |
| exposure environmental microorganisms | #2 |
| neu5gc role | #2 |
| multivariate analyses haying | #2 |
| association opposite direction | #2 |
| messenger receptors tenascin | #2 |
| ppg pha | #2 |
| maternal contact protective | #2 |
| farmers children children | #2 |
| card4 21596 children | #2 |
| 17q21 | #2 |
| atopic smokers | #2 |
| life pvalues | #2 |
| asthmaassociated | #2 |
| allergic tolllike receptor | #2 |
| allergies farming status | #2 |
| farmers asthma symptoms | #2 |
| milk cd14 | #2 |
| order sensitized patients | #2 |
| probability incidence | #2 |
| aa hc | #2 |
| eczema allergic dermatitis | #2 |
| improvements fdr | #2 |
| frequency nocturnal symptoms | #2 |
| strachan | #2 |
| role helminths | #2 |
| atopy early life | #2 |
| 95 school level | #2 |
| association allergic diseases | #2 |
| symptom control bmi | #2 |
| snps il4 gene | #2 |
| early life prevalence | #2 |
| antiige therapy response | #2 |
| bm190th | #2 |
| farming anthroposophic | #2 |
| antiidiotypic aspergillosis | #2 |
| cd14 genotypes asthma | #2 |
| demethylation foxp3 | #2 |
| asthma hygiene hypothesis | #2 |
| farms reference | #2 |
| wheeze 12 | #2 |
| microbial influences | #2 |
| highrisk predictors | #2 |
| cases objective measurements | #2 |
| school level 95 | #2 |
| children bronchial obstruction | #2 |
| standardized procedure centres | #2 |
| agriculture allergens | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| lessaffluent countries adolescents | #2 |
| low sensitization rates | #2 |
| prenatal farm exposure | #2 |
| sod3 transcript | #2 |
| atopic sensitization upregulation | #2 |
| lower atopy | #2 |
| childhood lca | #2 |
| animal exposure levels | #2 |
| higher greenness quartile | #2 |
| coaacetate | #2 |
| farm animals symptoms | #2 |
| ors affluent countries | #2 |
| current symptoms asthmaassociated | #2 |
| atopic eczema causation | #2 |
| patients childhood symptoms | #2 |
| halle west germany | #2 |
| allergic disorders children | #2 |
| 047 95 gg | #2 |
| farming families | #2 |
| prediction asthma | #2 |
| amish hutterite homes | #2 |
| socks alk samples | #2 |
| study design participation | #2 |
| influences development | #2 |
| asthma adolescence | #2 |
| life current symptoms | #2 |
| premature respiratory | #2 |
| t2inflammation | #2 |
| childhood symptoms relapse | #2 |
| exposures farm | #2 |
| alk samples | #2 |
| 14 260 | #2 |
| farm children | #2 |
| snps inflammatory diseases | #2 |
| farm milk pregnancy | #2 |
| foxp3 demethylation | #2 |
| cd4 cells offspring | #2 |
| microbial exposure risk | #2 |
| fdr clinical response | #2 |
| th17 markers | #2 |
| tirana mumbai | #2 |
| dust samples levels | #2 |
| farming mothers ppg | #2 |
| parsifal study phenotypes | #2 |
| adult arm alliance | #2 |
| il4 il13 pathway | #2 |
| pa interrelations | #2 |
| immune responses function | #2 |
| onset male recurrence | #2 |
| microbial agents association | #2 |
| associations lessaffluent countries | #2 |
| fev1 fdr | #2 |
| doctors diagnosed asthma | #2 |
| imposed social isolation | #2 |
| development atopic diseases | #2 |
| association atopic children | #2 |
| il4 gene | #2 |
| protection allergy | #2 |
| asthmaassociated aor | #2 |
| lipid lpa | #2 |
| symptom control pa | #2 |
| studies farms | #2 |
| hc ca2 | #2 |
| pregnancy specific ige | #2 |
| cd14 1721 association | #2 |
| dust endotoxin allele | #2 |
| sputum extracellular | #2 |
| children farm | #2 |
| consumption farm | #2 |
| consumption unpasteurized milk | #2 |
| followup ndvi | #2 |
| age asthma cohort | #2 |
| exposure lifestyle factors | #2 |
| positive spt sige | #2 |
| current exposure cats | #2 |
| rna russia | #2 |
| role maternal exposures | #2 |
| data maternal weight | #2 |
| improvements fdr score | #2 |
| pattern missing values | #2 |
| nonfarm homes children | #2 |
| bhr individual level | #2 |
| breathomics asthma | #2 |
| asthma symptoms eczema | #2 |
| immunoglobulin analyses children | #2 |
| eczema affluent | #2 |
| higher foxp3 | #2 |
| farmlike indoor microbiota | #2 |
| protein rhinitis allergic | #2 |
| affluent countries eczema | #2 |
| card4 21596 | #2 |
| fev1 fdr fdr | #2 |
| test inhalent | #2 |
| environmental microorganisms children | #2 |
| geneenvironment interactions asthma | #2 |
| atopic dermatitis wheeze | #2 |
| pha th17 lineage | #2 |
| fieldworkers house dust | #2 |
| associations hscrp levels | #2 |
| alternaria animals animals | #2 |
| rora asthma | #2 |
| difference endotoxin levels | #2 |
| eczema farm exposures | #2 |
| antibiotic asthma risk | #2 |
| nocturnal asthma life | #2 |
| nonfarming families | #2 |
| beta1 endotoxin | #2 |
| tregs cord blood | #2 |
| inflammatory diseases allergy | #2 |
| asthma meeting | #2 |
| leipzig halle | #2 |
| excessive edna production | #2 |
| opposite direction children | #2 |
| allergies genetic variation | #2 |
| cd14 maternal exposures | #2 |
| viable listeria spp | #2 |
| pha farming mothers | #2 |
| collected dust indoor | #2 |
| life increased risk | #2 |
| cd4cd25hi foxp3 | #2 |
| th2 cytokines ilc2s | #2 |
| amish farms | #2 |
| relation dust endotoxin | #2 |
| phase prevalence rates | #2 |
| grass pollen dander | #2 |
| eczema symptom prevalence | #2 |
| negative volatile organic | #2 |
| ifnγ levels snps | #2 |
| bronchial hyperresponsiveness children | #2 |
| early immune maturation | #2 |
| agmr 95 | #2 |
| relapse newonset | #2 |
| asthma phenotypes negative | #2 |
| igg4 ige levels | #2 |
| life rural children | #2 |
| allergic rhinitis adolescence | #2 |
| allele cd14 1721 | #2 |
| asthma protection | #2 |
| increased risk employment | #2 |
| immunoglobulin life | #2 |
| adaptor protein rhinitis | #2 |
| hutterite farm children | #2 |
| asthma control pa | #2 |
| ga²len harmonization | #2 |
| farming nonfarming families | #2 |
| processed cow | #2 |
| environmental microorganisms | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| rhinitis adolescents | #2 |
| bhr west germany | #2 |
| allergic diseases allergies | #2 |
| followup university | #2 |
| 645 children | #2 |
| living farms | #2 |
| increase parent | #2 |
| card4 association | #2 |
| socks dust | #2 |
| atopic diseases subjects | #2 |
| il13 gene linkage | #2 |
| fev1 score associations | #2 |
| siblings atopic children | #2 |
| affluent countries centers | #2 |
| tbx21 gene | #2 |
| developing allergies | #2 |
| increase worldwide | #2 |
| expression innate | #2 |
| influence cord | #2 |
| asthma cohort | #2 |
| fever west germany | #2 |
| atopic dermatitis childhood | #2 |
| asthma parsifal | #2 |
| cats eczema | #2 |
| histamine challenges | #2 |
| values edna concentrations | #2 |
| asthma symptoms fever | #2 |
| antit2 biological therapy | #2 |
| 95 047 95 | #2 |
| environmental exposures mother | #2 |
| cd14 1721 children | #2 |
| eczema conjunctivitis eczema | #2 |
| dresden higher greenness | #2 |
| paracetamol fever | #2 |
| time breastfed children | #2 |
| serum levels c4ma3 | #2 |
| children bronchial hyperresponsiveness | #2 |
| current paracetamol 95 | #2 |
| phase isaac | #2 |
| affluent countries | #2 |
| environmental microbial exposure | #2 |
| individual level bhr | #2 |
| asthma child dermatitis | #2 |
| bhr tirana | #2 |
| measles vaccination infection | #2 |
| parent asthma | #2 |
| fieldworkers dust collection | #2 |
| affluent countries associations | #2 |
| farming exposure | #2 |
| children nonfarm homes | #2 |
| dendritic cells dust | #2 |
| highdna | #2 |
| causation environmental associations | #2 |
| card4 protein rhinitis | #2 |
| subsample children | #2 |
| farming families allergies | #2 |
| th17 lineage markers | #2 |
| neu5gc exposure | #2 |
| exposure farming | #2 |
| polymorphisms card4 | #2 |
| frequency nocturnal asthma | #2 |
| allele card4 21596 | #2 |
| farming environment allergies | #2 |
| interactions asthma | #2 |
| persistent flexural eczema | #3 |
| asthma cattle | #3 |
| children bronchial hyperreactivity | #3 |
| risk nonatopic asthma | #3 |
| lukas2 birth | #3 |
| role adam33 polymorphisms | #3 |
| monocytes lps stimulation | #3 |
| hlx1 gene | #3 |
| asthma genetic severity | #3 |
| ile117thr | #3 |
| 1q31 locus | #3 |
| atopic sensitisation | #3 |
| dresden odds ratio | #3 |
| atopic mothers | #3 |
| food year | #3 |
| crosssectional population | #3 |
| 45yearold children | #3 |
| blood allergen | #3 |
| onset asthma child | #3 |
| c1407t | #3 |
| role neu5gc | #3 |
| bhr pcdh1 polymorphisms | #3 |
| protection development | #3 |
| domestic arthritis | #3 |
| allergic phenotype polymorphism | #3 |
| markers fetal growth | #3 |
| auc asthma | #3 |
| prenatal asthma protection | #3 |
| wheezing neutrophils | #3 |
| eczema international study | #3 |
| role asthma prevalence | #3 |
| farm dust endotoxin | #3 |
| il15 associations | #3 |
| gni rho | #3 |
| g1258a | #3 |
| perennial allergens paf | #3 |
| eczema col29a1 | #3 |
| locus dennd1b | #3 |
| childhood asthma community | #3 |
| hlx1 gene variants | #3 |
| col29a1 expression eczema | #3 |
| endotoxin milk | #3 |
| severity moisture damage | #3 |
| atopy dresden | #3 |
| samples 1q31 locus | #3 |
| crude measure | #3 |
| dennd1b chromosome | #3 |
| prevalence asthma | #3 |
| role atopic sensitization | #3 |
| tlr2 polymorphisms | #3 |
| t12888c | #3 |
| dennd1b asthma | #3 |
| moraxella colonization | #3 |
| german children munich | #3 |
| asthma atopic sensitization | #3 |
| hygiene hypothesis development | #3 |
| occurrence rhinitis | #3 |
| farm contact | #3 |
| eczema farmers | #3 |
| rhinitis increased risk | #3 |
| biomaterial collection | #3 |
| current asthma rhinoconjunctivitis | #3 |
| growing farm | #3 |
| prenatal protection | #3 |
| atopic dermatitis aor | #3 |
| young adult europe | #3 |
| today1 | #3 |
| farm animals farm | #3 |
| tlr2 amino acid | #3 |
| atopic asthma effects | #3 |
| european science foundation | #3 |
| putative functional role | #3 |
| c746t | #3 |
| allergy protection | #3 |
| bacterial diversity asthma | #3 |
| food correction | #3 |
| dogs exposure | #3 |
| regular contact | #3 |
| nf kappa polymorphism | #3 |
| lwoffii f78 | #3 |
| il15 il15 associations | #3 |
| munich polymorphism | #3 |
| susceptibility col29a1 expression | #3 |
| cd14 association | #3 |
| mmp9 variants risk | #3 |
| children african ancestry | #3 |
| 53152 | #3 |
| pcr sscp analysis | #3 |
| 1431c | #3 |
| cowshed dust | #3 |
| sige asthma | #3 |
| col29a1 polymorphisms | #3 |
| asthma subphenotypes | #3 |
| substances protection | #3 |
| atopic female germany | #3 |
| albania antibody specificity | #3 |
| gni measurements | #3 |
| characteristics respiratory | #3 |
| prenatal protection asthma | #3 |
| experimental asthma progeny | #3 |
| populations illness surveys | #3 |
| exposure helminths | #3 |
| microbiota farm | #3 |
| protocadherin‐1 | #3 |
| paf sensitisation | #3 |
| allergic diseases children | #3 |
| blatella | #3 |
| cytokine cluster bhr | #3 |
| rhinoconjunctivitis paf | #3 |
| age 7–10 years | #3 |
| sod3 extracellular matrix | #3 |
| allergy a20 induction | #3 |
| arabinogalactan isolated | #3 |
| protection contre | #3 |
| bavaria obesity | #3 |
| puberty risk factors | #3 |
| asthma protection progeny | #3 |
| bias asthma bias | #3 |
| anthroposophic children | #3 |
| dcs a20 induction | #3 |
| f78 | #3 |
| throat microbiota asthma | #3 |
| conjunctivitis paf | #3 |
| pcdh1 polymorphisms associations | #3 |
| farming farm | #3 |
| polymorphisms hlx1 gene | #3 |
| asthma 1431c | #3 |
| pcdh1 asthma | #3 |
| asthma pcdh1 | #3 |
| paf allergic | #3 |
| hlx1 gene development | #3 |
| amino acid cx3cr1 | #3 |
| environmental dusts | #3 |
| parent prevalence | #3 |
| il15 gene asthma | #3 |
| prevalence allergies | #3 |
| ppg expression | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| phase international study | #3 |
| culture techniques study | #3 |
| asthma snp rs2786098 | #3 |
| overweight germany | #3 |
| organic waste storage | #3 |
| isaac polymorphisms | #3 |
| bhr haplotypes humans | #3 |
| domestic asthma | #3 |
| genetic variation crth2 | #3 |
| questionnaires physical examination | #3 |
| sensitisation affluent countries | #3 |
| progeny asthma | #3 |
| 1q31 locus dennd1b | #3 |
| doctors diagnosis | #3 |
| children negative spts | #3 |
| disequilibrium rhinitis allergic | #3 |
| european ancestry asthma | #3 |
| asthma endotoxin levels | #3 |
| ferme | #3 |
| duration prevalence | #3 |
| asthma tolllike receptors | #3 |
| allergic disequilibrium rhinitis | #3 |
| asthma bordetella | #3 |
| farms asthma | #3 |
| 95ci nonatopic asthma | #3 |
| associations pcdh1 | #3 |
| atopic diseases mutations | #3 |
| 1431c specific ige | #3 |
| breastfeeding overweight | #3 |
| eczema strong association | #3 |
| effects single snps | #3 |
| responses innate | #3 |
| col29a1 polymorphisms eczema | #3 |
| countries endotoxin levels | #3 |
| animal sheds | #3 |
| endotoxin dust samples | #3 |
| germany west german | #3 |
| c39134a | #3 |
| vivo expression irf1 | #3 |
| c2892 | #3 |
| life allergic diseases | #3 |
| endotoxin levels asthma | #3 |
| individual level questionnaires | #3 |
| forward initiative | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| adam33 snps | #3 |
| adam33 polymorphisms asthma | #3 |
| stat6 haplotype | #3 |
| protein rhinitis | #3 |
| —study | #3 |
| stat1 gene variations | #3 |
| sod3 variants | #3 |
| asthma identified | #3 |
| allergic inflammation polymorphisms | #3 |
| seasonal allergens atopy | #3 |
| il5 c746t | #3 |
| microorganisms dust | #3 |
| 9 mmp9 mmp9 | #3 |
| network construction | #3 |
| eosinophil pathway genes | #3 |
| eosinophil pathway | #3 |
| rural areas europe | #3 |
| crth2 influences development | #3 |
| hygiene hypothesis | #3 |
| mmp9 influence development | #3 |
| mmp9 variants mmp9 | #3 |
| t3085 | #3 |
| treatment asthma phenotypes | #3 |
| allergyprotective | #3 |
| fever aor | #3 |
| eosinophils matrix metalloproteinase | #3 |
| cowshed dust extract | #3 |
| tlr2 receptor function | #3 |
| increased treg cells | #3 |
| bdnf polymorphisms asthma | #3 |
| cohort alliance | #3 |
| allergic phenotypes correction | #3 |
| 280met | #3 |
| stat6 gene regulation | #3 |
| children farming | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| female fetus immunity | #3 |
| rural dwellings | #3 |
| col29a1 variants eczema | #3 |
| il5 il5 c746 | #3 |
| asthma genetic association | #3 |
| paracetamol risk | #3 |
| allergic asthmatics aa | #3 |
| protective farm | #3 |
| united kingdom albania | #3 |
| col29a1 genetic variants | #3 |
| farming status | #3 |
| eczema isaac phase | #3 |
| 3099 children | #3 |
| il15 gene variants | #3 |
| 1000 enfants | #3 |
| jobrelated chronic stress | #3 |
| asthma major | #3 |
| life development | #3 |
| irf1 interferon expression | #3 |
| nonatopic asthma 95ci | #3 |
| asthma farming environment | #3 |
| maternal tlr | #3 |
| wheeze allergy | #3 |
| affluent countries atopy | #3 |
| rare tlr2 mutations | #3 |
| asthma amino acid | #3 |
| paf seasonal allergens | #3 |
| individual level centers | #3 |
| children isaac phase | #3 |
| polymorphisms gm csf | #3 |
| population german | #3 |
| col29a1 eczema | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| work work overload | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| il5 c746 allergic | #3 |
| farm dwellings | #3 |
| east germany bhr | #4 |
| asthma symptoms association | #4 |
| asthma medication exposure | #4 |
| stables farm milk | #4 |
| aetiology asthma | #4 |
| sounds rhinitis | #4 |
| inhalant patients | #4 |
| allergic il5 | #4 |
| heating prevalence | #4 |
| bacillus licheniformis spores | #4 |
| current asthma bhr | #4 |
| lower risk allergy | #4 |
| predictors visits | #4 |
| cough bronchitis | #4 |
| col29a1 expression | #4 |
| parent odds ratio | #4 |
| risk factor symptoms | #4 |
| n2267 | #4 |
| feeding prevalence | #4 |
| occupational allergy risks | #4 |
| predictor wheezing | #4 |
| exposure microbial | #4 |
| asthma snps | #4 |
| genes il4r | #4 |
| adult lung disease | #4 |
| benzene no2 | #4 |
| permanovas | #4 |
| environmental dust samples | #4 |
| rare tlr2 | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| lifetime prevalence asthma | #4 |
| endotoxin relation | #4 |
| flexural eczema | #4 |
| antibiotics antipyretics | #4 |
| prevalence random | #4 |
| children mattresses | #4 |
| particle boluses | #4 |
| promoter region arg130gln | #4 |
| cord blood lipid | #4 |
| asthma current symptoms | #4 |
| doctors diagnosis asthma | #4 |
| lrti asthma | #4 |
| eczema flg mutations | #4 |
| pro27ser | #4 |
| occurrence atopic dermatitis | #4 |
| questionnaires adolescent eczema | #4 |
| glu420lys | #4 |
| german children bavaria | #4 |
| childhood protect | #4 |
| sas genetics | #4 |
| asthma symptoms adults | #4 |
| dust personal | #4 |
| lukas2 | #4 |
| allergic diseases humans | #4 |
| asthma atopic diseases | #4 |
| cx3cr1 polymorphisms | #4 |
| agreement spt | #4 |
| cromolyns | #4 |
| leisure time activity | #4 |
| current symptoms asthma | #4 |
| tolllike receptors receptor | #4 |
| nonfarming | #4 |
| development atopic | #4 |
| spt sige | #4 |
| gabriel advanced | #4 |
| asthma hygiene | #4 |
| early identification atopy | #4 |
| c746 | #4 |
| asthma auc | #4 |
| immunity receptors | #4 |
| tlr2 mutations | #4 |
| parental allergic rhinitis | #4 |
| microbes asthma | #4 |
| factors wheeze | #4 |
| mother role | #4 |
| anthroposophic families | #4 |
| fever year | #4 |
| asthma phenotype children | #4 |
| col29a1 gene | #4 |
| allergic dermatitis allergic | #4 |
| fever 17 | #4 |
| wheeze ige levels | #4 |
| life childhood | #4 |
| groups taxa | #4 |
| a20 induction | #4 |
| allergies children | #4 |
| genetic rhinitis allergic | #4 |
| infections early | #4 |
| fetal growth asthma | #4 |
| secretory receptors allergic | #4 |
| late phenotype | #4 |
| common sensitizations | #4 |
| allergy international study | #4 |
| fatty acids allergic | #4 |
| cats pregnancy | #4 |
| wheeze bhr | #4 |
| incident sensitization | #4 |
| fever eczema | #4 |
| crp blood leukocytes | #4 |
| indoor pollen | #4 |
| microbial compounds | #4 |
| ige levels associations | #4 |
| early life basis | #4 |
| initial data analysis | #4 |
| childhood asthma | #4 |
| alliance cohort | #4 |
| h20like homeobox | #4 |
| wheezing onset | #4 |
| gene expression receptors | #4 |
| asthma induction | #4 |
| asthma 3 | #4 |
| licheniformis spores | #4 |
| adolescents duration | #4 |
| exposure cats | #4 |
| children munich | #4 |
| 5 13 years | #4 |
| stable dust | #4 |
| ilc2s human asthma | #4 |
| t2high asthma | #4 |
| cheese consumption | #4 |
| questionnaires eczema | #4 |
| phase 2 allergies | #4 |
| farm environment development | #4 |
| neonatal window | #4 |
| genetic nod1 | #4 |
| genotypes cd14 | #4 |
| birth atopic dermatitis | #4 |
| human genetic nod1 | #4 |
| rs2786098 | #4 |
| environmental factors development | #4 |
| 95 gene expression | #4 |
| study centers phase | #4 |
| cd4cd25hi tregs | #4 |
| allergic ecuador eczema | #4 |
| atopic dermatitis birth | #4 |
| questionnaires populations | #4 |
| increase eczema prevalence | #4 |
| minimum battery | #4 |
| 99th dahlem conference | #4 |
| cowsheds | #4 |
| participants fieldworkers | #4 |
| candidate genes wheeze | #4 |
| development atopic sensitization | #4 |
| risk atopic dermatitis | #4 |
| eczema questionnaires adolescent | #4 |
| dietary habits children | #4 |
| prenatal asthma | #4 |
| children maternal overweight | #4 |
| il4r tlr4 | #4 |
| birthcohort study | #4 |
| children farms | #4 |
| thr280met | #5 |
| 2nd followup | #5 |
| delayed manifestation | #5 |
| endotoxin protection | #5 |
| dresden | #5 |
| risk atopic | #5 |
| combination hlx1 polymorphisms | #5 |
| ormdl3 gsdma | #5 |
| dogs symptoms | #5 |
| nonfarmers children | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| children validity | #5 |
| rural subjects | #5 |
| associations wheeze | #5 |
| processing intensity | #5 |
| subtypes risk | #5 |
| inverse association overweight | #5 |
| communitybased random sample | #5 |
| cowshed | #5 |
| life questionnaires switzerland | #5 |
| childhood isaac phase | #5 |
| nod1 variation | #5 |
| ige regulation | #5 |
| genetic asthma | #5 |
| incident wheeze | #5 |
| genetic variants tbx21 | #5 |
| 14452 | #5 |
| il13cd4 cells | #5 |
| cd14 gene expression | #5 |
| atopy airway hyperresponsiveness | #5 |
| tests bronchitis | #5 |
| asthma child dust | #5 |
| west german children | #5 |
| tbx21 gene variants | #5 |
| milk odds | #5 |
| receptors innate immunity | #5 |
| mmp9 influence | #5 |
| allergic diseases exposure | #5 |
| jf1 msf | #5 |
| tbx21 promoter activity | #5 |
| verlaufsformen | #5 |
| flexural eczema strength | #5 |
| atopic dermatitis age | #5 |
| linkage development | #5 |
| allergystudy | #5 |
| sensitization atopic | #5 |
| wisconsin infant | #5 |
| 95 populationattributable risk | #5 |
| asthma girls | #5 |
| ors atopy | #5 |
| rs3771300 | #5 |
| 2q14 | #5 |
| hyperreactivity child | #5 |
| hlx1 polymorphisms development | #5 |
| young adults methods | #5 |
| phänotypen | #5 |
| milk exposure | #5 |
| hlx1 variants | #5 |
| consumption 4 years | #5 |
| influence ige | #5 |
| environmental dust | #5 |
| moulds actinomycetes | #5 |
| farming mothers | #5 |
| severe atopy | #5 |
| parental reports asthma | #5 |
| cow milk samples | #5 |
| pregnancy year | #5 |
| duration jobs | #5 |
| ornonaffluent | #5 |
| children current wheeze | #5 |
| il13cd4 | #5 |
| eczema relation | #5 |
| combination hlx1 variants | #5 |
| atopic sensitization asthma | #5 |
| 26 farms | #5 |
| tnc nps | #5 |
| atopy flexural eczema | #5 |
| asthma endotoxins | #5 |
| lung health disease | #5 |
| ors positive association | #5 |
| timing exposures | #5 |
| neu5gc mice | #5 |
| tbx21 combination | #5 |
| participation behaviour | #5 |
| milk consumption age | #5 |
| visits predictors | #5 |
| tbx21 polymorphisms development | #5 |
| allergic rhinitis wheeze | #5 |
| 95 reverse causation | #5 |
| atopic eczema allergic | #5 |
| cd4cd25hi | #5 |
| asthma medication 95 | #5 |
| cats risk factor | #5 |
| helsinki alert | #5 |
| c2892t | #5 |
| adulthood asthma | #5 |
| agriculture animals | #5 |
| pattern sensitization | #5 |
| moisture mold problems | #5 |
| airway responsiveness age | #5 |
| exposure rhinitis | #5 |
| n1046 | #5 |
| trigger factors asthma | #5 |
| popular terms | #5 |
| disinfectants asthma | #5 |
| allergen 95 | #5 |
| rhinitis increase | #5 |
| puberty menarche | #5 |
| taxa groups | #5 |
| female germany allergic | #5 |
| mechanism environmental factors | #5 |
| allergens needed | #6 |
| pair male nod2 | #6 |
| countries albania | #6 |
| tests asthma | #6 |
| allergic epistasis | #6 |
| lung barrier | #6 |
| comprehensive questionnaires | #6 |
| protection allergies | #6 |
| children east germany | #6 |
| new locus time | #6 |
| lifestyle factors symptoms | #6 |
| longitudinal populations | #6 |
| microorganisms samples | #6 |
| abschnitten | #6 |
| asthma transition | #6 |
| polymorphisms stat6 gene | #6 |
| steiner schools | #6 |
| progression asthma | #6 |
| current contact | #6 |
| genetic variants 17q12q21 | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| cold air challenge | #6 |
| central europe interactions | #6 |
| asthma austria | #6 |
| 939 children | #6 |
| data 7 years | #6 |
| bavarian preschool children | #6 |
| pair deubiquitinating enzyme | #6 |
| tlr1 tlr10 | #6 |
| sensitisation exposure | #6 |
| il33 17q12q21 | #6 |
| strategies disease | #6 |
| eating environmental | #6 |
| fever atopy | #6 |
| genetic variants time | #6 |
| distinct underlying mechanisms | #6 |
| no2 current asthma | #6 |
| 5 regions tao | #6 |
| oropharyngeal microbiota | #6 |
| devenues | #6 |
| isaac programme | #6 |
| asthma authors | #6 |
| atemwegserkrankungen | #6 |
| allergic immunologic receptors | #6 |
| nonaffluent | #6 |
| inversely asthma | #6 |
| pierced ears | #6 |
| farm nonfarm | #6 |
| complete screening | #6 |
| rora npsr1 | #6 |
| primary preventive strategies | #6 |
| dust collection | #6 |
| asthma context | #6 |
| responders frequency | #6 |
| sscp method | #6 |
| lowgrade inflammation hscrp | #6 |
| european dairy farms | #6 |
| prevent allergic | #6 |
| allergic diseases | #6 |
| fever wheezing | #6 |
| susceptibility gene asthma | #6 |
| allergoprotective properties | #6 |
| bolus dispersion | #6 |
| rhinoconjunctivitis atopic | #6 |
| childhood aa | #6 |
| nd132656 | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| rhinoconjunctivitis eczema | #6 |
| 17q12q21 earlier onset | #6 |
| study rarer snps | #6 |
| food allergy 95 | #6 |
| dogs environmental exposure | #6 |
| parsifal | #6 |
| childhood asthma phenotypes | #6 |
| asthma allergic sensitisation | #6 |
| interactions farm exposures | #6 |
| allergy tests children | #6 |
| onset disease germany | #6 |
| children farming environment | #6 |
| 7 years association | #6 |
| overweight data | #6 |
| children positive spt | #6 |
| allergic markers | #6 |
| asthma genotypes | #6 |
| natural atopic dermatitis | #6 |
| 16q12 region | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| deubiquitinating enzyme tao | #6 |
| sounds surveys | #6 |
| 11094 | #6 |
| systemic inflammation age | #6 |
| central europe asthma | #6 |
| hypertonic skin tests | #6 |
| yearly interviews | #6 |
| german nationality | #6 |
| childhood asthma genes | #6 |
| atopic dermatitis association | #7 |
| birth function | #7 |
| 95 endotoxin | #7 |
| allergic atopic embryonic | #7 |
| genetic predisposition role | #7 |
| asthma environmental factors | #7 |
| infantis populations | #7 |
| pasture study | #7 |
| interleukin4 sequence analysis | #7 |
| centers increase | #7 |
| pasture birth | #7 |
| environmental factors children | #7 |
| childhoodonset disease | #7 |
| rhinitis early childhood | #7 |
| aerosol bolus dispersion | #7 |
| child dust | #7 |
| stat1 gene | #7 |
| diversity introduction | #7 |
| farm life | #7 |
| influence neonatal | #7 |
| symptoms adulthood | #7 |
| hypersensitivity male | #7 |
| murine offspring | #7 |
| foxp3 blood | #7 |
| invading microorganism | #7 |
| steiner school children | #7 |
| isaac eczema | #7 |
| inhalant age | #7 |
| children international study | #7 |
| european science | #7 |
| lower risk asthma | #7 |
| atopic europe | #7 |
| wheeze 12 months | #7 |
| 5 harmonization | #7 |
| functional phenotypes | #7 |
| lung sod3 | #7 |
| farm homes | #7 |
| breastfeeding prevalence | #7 |
| polymorphisms il4 gene | #7 |
| immunologic receptors allergic | #7 |
| biomarker immune activation | #7 |
| questionnaires allergic | #7 |
| cells dust | #7 |
| questionnaires phase | #7 |
| birth cohorts report | #7 |
| association cord blood | #7 |
| juvenile inflammatory | #7 |
| children prognosis | #7 |
| lymphoid cells asthma | #7 |
| inverse association consumption | #7 |
| seasonal sensitivity allergic | #7 |
| children breast | #7 |
| children regular contact | #7 |
| school age asthma | #7 |
| endotoxin allergen | #7 |
| adult farmers | #7 |
| farm exposure | #7 |
| pbmcs asthmatics | #7 |
| reference exposure | #7 |
| exposure farms | #7 |
| allergy antibiotics | #7 |
| fieldworkers | #7 |
| indoor moisture | #7 |
| asthma school age | #7 |
| large centres | #7 |
| strategies asthma | #7 |
| fetal development allergic | #7 |
| grass rphl | #7 |
| hypertonic sensitivity | #7 |
| bhr current asthma | #7 |
| viral infections development | #7 |
| paracetamol year | #7 |
| asthma fever | #7 |
| amish children | #7 |
| highrisk occupations | #7 |
| preanalytix | #7 |
| steiner school | #7 |
| 15245 | #7 |
| nonfarm homes | #7 |
| hutterite children | #7 |
| levels farm | #7 |
| exposure neu5gc | #7 |
| perennial allergen | #7 |
| level variety | #7 |
| secretory receptors | #7 |
| environmental exposure endotoxin | #7 |
| pregnancy atopic dermatitis | #7 |
| infectious diseases phenotype | #7 |
| childrens bedrooms | #7 |
| wheeze atopy | #7 |
| log2fold | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| fever atopic asthma | #7 |
| chromosome 2q14 | #8 |
| fever atopic sensitisation | #8 |
| eczema asthma child | #8 |
| il13 variants | #8 |
| p7×10−14 | #8 |
| atopic sensitization prevalence | #8 |
| children anthroposophic | #8 |
| inhalant europe | #8 |
| university work | #8 |
| il15 snps | #8 |
| asthma analyses | #8 |
| allergies childhood | #8 |
| asthma birth weight | #8 |
| surveyed children | #8 |
| asthma physiciandiagnosed asthma | #8 |
| rs8076131 | #8 |
| hrqol questions | #8 |
| 824 children | #8 |
| highthroughput sequencing data | #8 |
| genetic risk asthma | #8 |
| exposure dogs | #8 |
| diversity year | #8 |
| sensitization patterns | #8 |
| hlx1 | #8 |
| 3113 children | #8 |
| international variations | #8 |
| dogs risk factor | #8 |
| immunity gene expression | #8 |
| asthma child conjunctivitis | #8 |
| cows milk age | #8 |
| children anthroposophic families | #8 |
| c4ma3 | #8 |
| igg1 galactosylation | #8 |
| gabriela study | #8 |
| allergy study | #8 |
| asthma maternal smoking | #8 |
| age 911 years | #8 |
| current asthma data | #8 |
| amino acid asthma | #8 |
| amish child | #8 |
| 17q12q21 | #8 |
| finlande | #8 |
| lipid peptidoglycan | #8 |
| mice children | #8 |
| allergy epidemiology | #8 |
| crohns disease polymorphisms | #8 |
| childhoodonset disease elevation | #8 |
| agmr | #8 |
| gabriela | #8 |
| ppg stimulation | #8 |
| factor analysis factor | #8 |
| children reference | #8 |
| influence cytokine | #8 |
| bronchial histamine challenge | #8 |
| 95 food allergy | #8 |
| association food diversity | #8 |
| diet year | #8 |
| early age exposure | #8 |
| chromosome childhoodonset disease | #8 |
| childhood asthma atopy | #8 |
| antibiotics year | #8 |
| proteins dendritic cells | #8 |
| sensitization mite | #8 |
| asthma bias | #8 |
| asthmaprotective | #8 |
| invertedu shape | #8 |
| study rural | #8 |
| asthma 08 | #8 |
| age positive spts | #8 |
| indoor microbiota | #8 |
| repeats sequence homology | #8 |
| p4×10−9 | #8 |
| th2 cells ilc2s | #8 |
| association wheeze | #8 |
| airwayrelated symptoms | #8 |
| p3×10−9 | #8 |
| austrian schoolchildren | #8 |
| asthma atopic sensitisation | #8 |
| p11×10−8 | #8 |
| subspecies bifidobacterium | #9 |
| allergic seasonal risk | #9 |
| rad50 gene chromosome | #9 |
| asthma child | #9 |
| role human asthma | #9 |
| allergic inflammation patients | #9 |
| gwas approaches | #9 |
| cytokines environmental | #9 |
| asthma allergy symptoms | #9 |
| ige levels gwas | #9 |
| animals supplementation | #9 |
| autriche | #9 |
| n7498 | #9 |
| 105 years age | #9 |
| npsr1 snps | #9 |
| 1314 children | #9 |
| skinprick | #9 |
| microbial substances | #9 |
| allergic preschool conjunctivitis | #9 |
| positive spts | #9 |
| eczema weight | #9 |
| 1314yrolds | #9 |
| atopic sensitization children | #9 |
| asthma symptoms baseline | #9 |
| fcer1a susceptibility locus | #9 |
| prevalence atopic | #9 |
| symptoms 12 months | #9 |
| ribosomal 16s risk | #9 |
| ecuador eczema | #9 |
| life prenatal exposure | #9 |
| germany munich | #9 |
| random subsample | #9 |
| col29a1 variants | #9 |
| asthma antibiotics | #9 |
| kazal type | #9 |
| asthma child child | #9 |
| levels allergens | #9 |
| dennd1b | #9 |
| association wheezing | #9 |
| drug development strategies | #9 |
| farming environment | #9 |
| teenagers asthma | #9 |
| chromosome ige levels | #9 |
| relation environment | #9 |
| 1 npsr1 | #9 |
| regular exposure | #9 |
| ausprägungen | #9 |
| life female germany | #9 |
| 5 european | #9 |
| regulatory th17 cells | #9 |
| tbx21 promoter | #9 |
| asthma risk | #9 |
| conjunctivitis cross | #9 |
| igg4 ige | #9 |
| clinical response score | #9 |
| asthma respiratory conditions | #9 |
| association stat6 variation | #9 |
| asthma infant | #9 |
| bronchial hyper‐responsiveness | #9 |
| asthma early life | #9 |
| unprocessed milk | #9 |
| rural farm | #9 |
| young german | #9 |
| factors sensitization | #9 |
| low levels hscrp | #9 |
| study asthma | #9 |
| partial nonresponders | #9 |
| longitudinal follow‐up | #9 |
| cord blood cytokines | #9 |
| allergic phenotypes | #9 |
| relation asthma | #9 |
| microbial exposure | #9 |
| life ahr | #9 |
| polymorphisms development | #9 |
| exposure farming environments | #9 |
| humans hypersensitivity | #10 |
| 1992–2001 | #10 |
| association atopic | #10 |
| mattress dust | #10 |
| new zealand bhr | #10 |
| young german adults | #10 |
| 45 saline | #10 |
| asthma nocturnal | #10 |
| ilt3 ilt4 | #10 |
| predictors health utilization | #10 |
| countries centres | #10 |
| ratio asthma | #10 |
| bdnf gene variants | #10 |
| production cord blood | #10 |
| bhr prevalence | #10 |
| interrelations risk factors | #10 |
| missing values paper | #10 |
| blood samples tubes | #10 |
| mothers contact | #10 |
| international study asthma | #10 |
| early life immunity | #10 |
| gabriel advanced studies | #10 |
| atopic dermatitis 95 | #10 |
| substances development | #10 |
| n1138 | #10 |
| phase protocol | #10 |
| bias exposure | #10 |
| ige levels asthma | #10 |
| life allergen | #10 |
| receptors immunity | #10 |
| farm exposures asthma | #10 |
| prevalence differences | #10 |
| centers prevalence rates | #10 |
| endotoxin muramic acid | #10 |
| leipzig east germany | #10 |
| rural school children | #10 |
| new onset rhinitis | #10 |
| latex children | #10 |
| mechanisms oral tolerance | #10 |
| urban rural area | #10 |
| farm children children | #10 |
| genetic probability receptors | #10 |
| indoor heating | #10 |
| house dust endotoxin | #10 |
| airway hyperresponsiveness children | #10 |
| adult cases controls | #10 |
| infection allergic | #10 |
| consumption raw | #10 |
| context eczema | #10 |
| asthma chromosome | #10 |
| reservoir method | #10 |
| study occupational | #10 |
| hormonal factors role | #10 |
| association new onset | #10 |
| npsr1 polymorphisms | #11 |
| transient wheezing | #11 |
| overweight body mass | #11 |
| reduced risk asthma | #11 |
| wheeze year | #11 |
| cytokines allergic inflammation | #11 |
| newborn male polymorphism | #11 |
| microbiome lung | #11 |
| health outcomes countries | #11 |
| tbx21 polymorphisms | #11 |
| persistent uncontrolled asthma | #11 |
| school beginners | #11 |
| lebensbedingungen | #11 |
| parsifal study | #11 |
| ige measurements | #11 |
| fetal ige | #11 |
| atopy | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| active smoking association | #11 |
| children rural | #11 |
| samples persons | #11 |
| farm exposures | #11 |
| genotyped polymorphisms | #11 |
| association respiratory health | #11 |
| allergic asthma conjunctivitis | #11 |
| asthma lower | #11 |
| allergy risks | #11 |
| blood foxp3 | #11 |
| asthma risk participants | #11 |
| protective development | #11 |
| tuberculosis notification rates | #11 |
| factors agriculture | #11 |
| asthma bacterial | #11 |
| german schoolchildren | #11 |
| subsequent development asthma | #11 |
| wheeze aor | #11 |
| pregnancy early life | #11 |
| allergic disease children | #11 |
| atopic dust | #11 |
| children school entry | #11 |
| farm buildings | #11 |
| occupational disinfectants | #11 |
| early life development | #11 |
| rural environments | #12 |
| cattle child | #12 |
| multicentre allergy | #12 |
| east germany munich | #12 |
| children exposed children | #12 |
| asthma candidate gene | #12 |
| dermatitis phenotypes | #12 |
| exposure asthma symptoms | #12 |
| skin prick testing | #12 |
| age 105 years | #12 |
| 95 nox | #12 |
| hypersensitivity immunity | #12 |
| management childhood asthma | #12 |
| young adults school | #12 |
| participants allergic rhinitis | #12 |
| polymorphism asthma | #12 |
| increase prevalence | #12 |
| infection analyses | #12 |
| children low levels | #12 |
| child environmental | #12 |
| transient wheeze | #12 |
| validated questions | #12 |
| incident asthma 95 | #12 |
| doctor asthma | #12 |
| overweight breast | #12 |
| farm | #12 |
| early priming | #12 |
| asthma parent | #12 |
| asthmatic cohort | #12 |
| asthma epidemic | #12 |
| mattress dust samples | #12 |
| standard deviation skewness | #12 |
| 7 years data | #12 |
| female humans hypersensitivity | #12 |
| male respiratory | #12 |
| children background | #12 |
| bhr wheeze | #12 |
| backgroundasthma | #12 |
| damage mold | #12 |
| polymorphisms bdnf gene | #12 |
| asthma disease humans | #12 |
| sensitization birth | #12 |
| current paracetamol | #12 |
| german multicentre | #12 |
| ige grass | #12 |
| pet contact | #12 |
| birth cohorts asthma | #12 |
| munich west germany | #12 |
| stepwise protocol | #12 |
| symptoms atopic | #12 |
| association moisture | #12 |
| fever exposure | #12 |
| healthy children asthma | #12 |
| children polymorphisms | #13 |
| antibiotic exposure pregnancy | #13 |
| ibd sle | #13 |
| asthma nocturnal symptoms | #13 |
| children raised | #13 |
| childhood allergy | #13 |
| childhood isaac | #13 |
| npsr1 | #13 |
| asthma community | #13 |
| dresden germany | #13 |
| th1cells | #13 |
| asthma snp | #13 |
| rural schoolchildren | #13 |
| sx1 | #13 |
| spt specific ige | #13 |
| developing microbiota | #13 |
| children inhaled steroids | #13 |
| local immunity | #13 |
| n349 | #13 |
| asthma bronchial | #13 |
| farming exposures | #13 |
| subjects jobs | #13 |
| farm animal contact | #13 |
| polymorphisms influence | #13 |
| cord adult blood | #13 |
| groups phenotype | #13 |
| expression ormdl3 | #13 |
| occupational exposure disinfectants | #13 |
| farm dust | #13 |
| nod1 gene | #13 |
| allergic sensitisation children | #13 |
| wheezing ages | #13 |
| rhinitis allergens | #13 |
| atopic eczema symptoms | #13 |
| asthma outcomes patients | #13 |
| northern indiana | #13 |
| switzerland children | #13 |
| asthma rhinoconjunctivitis | #13 |
| eastern western germany | #13 |
| asthma mental health | #13 |
| hygiene hypersensitivity | #13 |
| asthma1 | #14 |
| burden prevalence | #14 |
| detailed questionnaires | #14 |
| german children | #14 |
| atopic environmental | #14 |
| untypical | #14 |
| introduction complementary food | #14 |
| farming lifestyle | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| breast feeding children | #14 |
| fx5 | #14 |
| changing gender | #14 |
| 7 polymorphisms | #14 |
| exacerbations fev1 | #14 |
| 3099 | #14 |
| diabimmune study | #14 |
| farm rural | #14 |
| air challenge | #14 |
| th2 commitment | #14 |
| mrna expression vivo | #14 |
| symptoms rhinoconjunctivitis | #14 |
| innate infant | #14 |
| delayed introduction solids | #14 |
| positive spts age | #14 |
| respiratory atopic | #14 |
| late introduction | #14 |
| nonaffluent countries | #14 |
| allergic sensitization age | #14 |
| polymorphisms ormdl3 | #14 |
| 10‐year‐old children | #14 |
| upper respiratory symptoms | #14 |
| preventive development | #14 |
| role lung microbiome | #14 |
| cross environmental exposure | #14 |
| il15 gene | #14 |
| standardised questionnaires | #14 |
| rhinitis conjunctivitis | #14 |
| diseases atopic | #14 |
| asthma step | #14 |
| increased risk age | #14 |
| maternal sensitization | #14 |
| incidence rhinitis | #14 |
| rhinitis puberty | #15 |
| asthma allergy | #15 |
| children early | #15 |
| allergy risk | #15 |
| pregnancy protective | #15 |
| skin prick tests | #15 |
| 17q21 locus | #15 |
| puberty rhinitis | #15 |
| children allele | #15 |
| dogs children | #15 |
| respective tlrs | #15 |
| association asthma symptoms | #15 |
| street residence | #15 |
| bronchial hyperreactivity | #15 |
| immunity asthma | #15 |
| allele2 | #15 |
| factors bronchial | #15 |
| allele evidence | #15 |
| epidemiological studies exposure | #15 |
| nocturnal symptoms | #15 |
| contact farm animals | #15 |
| diabimmune | #15 |
| unpasteurized | #15 |
| bronchial responsiveness children | #15 |
| sensitization indoor allergens | #15 |
| ahr male mice | #15 |
| ω3 polyunsaturated | #15 |
| mold problems | #15 |
| association atopy | #16 |
| increased food | #16 |
| burden childhood asthma | #16 |
| allergic diseases childhood | #16 |
| microbial exposures | #16 |
| diseases allergy | #16 |
| 9 11 | #16 |
| seasonal surveys questionnaires | #16 |
| bacteria respiratory tract | #16 |
| exposure atopic | #16 |
| polymorphisms atopy | #16 |
| lung microbiome health | #16 |
| protocadherin1 | #16 |
| hutterite | #16 |
| microbial environment | #16 |
| 80 chromosomes | #16 |
| newborn phenotype | #16 |
| nonatopic asthma children | #16 |
| n1133 | #16 |
| 7 year | #16 |
| multi‐centre study | #16 |
| chronic asthma children | #16 |
| wheeze trajectories | #16 |
| sas institute | #16 |
| clinical response measures | #16 |
| endotoxin house | #16 |
| asthma asthma risk | #16 |
| childhood asthma asthma | #16 |
| asthma farm | #16 |
| respiratory health children | #17 |
| epidemiologic dermatitis | #17 |
| asthma associations | #17 |
| asthma 95 | #17 |
| bavarian | #17 |
| pregnancy gene expression | #17 |
| age 7 years | #17 |
| child allergic | #17 |
| neuropeptide receptor npsr1 | #17 |
| factors atopic | #17 |
| single microbial | #17 |
| munich | #17 |
| munich germany | #17 |
| animals domestic | #17 |
| allergic asthma aa | #17 |
| rhinoconjunctivitis | #17 |
| asthma biomarkers humans | #17 |
| asthma immune responses | #17 |
| atopy childhood | #17 |
| function school | #17 |
| humans preschool haemophilus | #17 |
| asthma environment | #17 |
| eczema exposure | #17 |
| aerosol bolus | #17 |
| ga2len skin | #17 |
| variants increase | #17 |
| dust extract | #17 |
| levels microbial | #17 |
| persistent sensitization | #17 |
| col29a1 | #18 |
| trajectories asthma | #18 |
| increase childhood | #18 |
| measles infection | #18 |
| preschool dna ribosomal | #18 |
| anthroposophic lifestyle | #18 |
| underlying responses | #18 |
| german populations | #18 |
| meat children | #18 |
| mef75 | #18 |
| ormdl3 gene | #18 |
| cbmcs | #18 |
| pregnancy 6 years | #18 |
| wheeze | #18 |
| asthma exposure | #18 |
| type employment | #18 |
| female humans asthma | #18 |
| immune adaptation | #18 |
| polymorphism genetic receptors | #18 |
| phenotypes children | #18 |
| atopy rhinitis | #18 |
| current wheezers | #18 |
| asthma 6 years | #18 |
| 7 yrs | #18 |
| eczema 95 | #18 |
| childrens mattresses | #18 |
| maternallyacquired mice mice | #18 |
| children german | #18 |
| maternal contact | #18 |
| protective microbiota | #18 |
| cb production | #18 |
| edna concentrations | #18 |
| asthma phenotyping | #18 |
| asthma report | #19 |
| receptors innate immune | #19 |
| child crosssectional studies | #19 |
| poor symptom control | #19 |
| newonset symptoms | #19 |
| asthma allergy development | #19 |
| symptoms asthma | #19 |
| receptors innate | #19 |
| cary | #19 |
| ilt4 | #19 |
| regulatory tolllike receptor | #19 |
| susceptibility human | #19 |
| linkage disequilibrium polymorphisms | #19 |
| tcell phenotypes | #19 |
| asthma bronchiale | #19 |
| children current | #19 |
| rural children | #19 |
| innate mice models | #19 |
| seasonal risk | #19 |
| atopic dermatitis studies | #19 |
| farming activities | #19 |
| sounds risk | #19 |
| german center | #19 |
| higher levels endotoxin | #19 |
| life exposures | #19 |
| viable bacterial counts | #19 |
| expression treg | #19 |
| 3 years life | #19 |
| life asthma risk | #19 |
| life diversity | #19 |
| developing asthma | #19 |
| hscrp age | #19 |
| disease atopic | #19 |
| asthma | #19 |
| atopy phenotypes | #19 |
| microbial association networks | #19 |
| birth 13 years | #19 |
| crp levels age | #19 |
| arg130gln | #19 |
| infant colonization | #20 |
| 6 haplotype | #20 |
| npsr1 nps | #20 |
| symptoms wheeze | #20 |
| westernized countries | #20 |
| gender ratio | #20 |
| stables | #20 |
| disease germany | #20 |
| dermatitis early | #20 |
| specific ige food | #20 |
| breast feeding risk | #20 |
| gene expression measurements | #20 |
| isaac | #20 |
| unhygienic | #20 |
| animal exposure | #20 |
| allergic disease prevalence | #20 |
| haplotype studies | #20 |
| unboiled | #20 |
| dust female humans | #20 |
| adults childhood | #20 |
| mice sod3 | #20 |
| asthma trajectories | #20 |
| asthma nonatopic asthma | #20 |
| inbred balb spores | #20 |
| persistent uncontrolled | #20 |
| farm environments | #20 |
| school university | #20 |
| children living | #20 |
| life farm | #20 |
| pvalues patients | #20 |
| atopy snps | #20 |
| bifidobacterium colonization | #21 |
| patients degradation | #21 |
| c589t | #21 |
| network differences | #21 |
| n1062 | #21 |
| bhr 95 | #21 |
| gstm1 deficiency | #21 |
| turkish children | #21 |
| current asthma wheeze | #21 |
| hypersensitivity infant | #21 |
| markers early | #21 |
| studies eczema | #21 |
| development allergic diseases | #21 |
| pseudocroup | #21 |
| tlr2 receptor | #21 |
| children east | #21 |
| children inhaled | #21 |
| prevalence rates symptoms | #21 |
| farm environment | #21 |
| plasma erythrocyte membranes | #21 |
| atopic asthma children | #21 |
| environment lifestyle | #21 |
| eczema atopy | #21 |
| pregnancy production | #21 |
| environmental microbiome | #21 |
| unremitting | #21 |
| ige igg4 | #21 |
| rora | #21 |
| childhood background | #21 |
| tripeptidylpeptidases | #21 |
| germany humans germany | #21 |
| asthma review | #21 |
| chromosome asthma | #22 |
| samples dust | #22 |
| endotoxin house dust | #22 |
| r753q | #22 |
| lps risk | #22 |
| β1→3glucans | #22 |
| gabriel | #22 |
| muramic acid | #22 |
| effective airway | #22 |
| immune maturation | #22 |
| exposure germany | #22 |
| living germany | #22 |
| crth2 th2 cells | #22 |
| food diversity | #22 |
| 17q21 asthma | #22 |
| seasonal risk factors | #22 |
| highschool | #22 |
| 95 prenatal exposure | #22 |
| neonatal immune responses | #22 |
| objective sought | #22 |
| feeding obesity | #22 |
| isaac childhood | #22 |
| lower prevalences | #22 |
| npsr1 gene | #22 |
| allergic rhinitis 95 | #22 |
| alleles asthma | #22 |
| respiratory diseases children | #22 |
| childhood atopy | #22 |
| asthmatic phenotypes | #22 |
| nonfarm | #23 |
| 7 prevalence | #23 |
| fecal microbiota children | #23 |
| single taxa | #23 |
| bronchial challenge tests | #23 |
| childhood allergies | #23 |
| rapid alternative | #23 |
| farm childhood | #23 |
| breast feeding asthma | #23 |
| children adulthood | #23 |
| isaac phase | #23 |
| traffic counts | #23 |
| microbiota respiratory | #23 |
| asthma cats | #23 |
| hillerød | #23 |
| child cross | #23 |
| gross national | #23 |
| asthma 12 months | #23 |
| asthma agents | #23 |
| new onset | #23 |
| southern bavaria | #23 |
| nonlinear relations | #23 |
| symptoms atopic eczema | #23 |
| association atopic asthma | #23 |
| asthma bhr | #24 |
| current symptoms | #24 |
| differences asthma prevalence | #24 |
| tobit regression | #24 |
| asthma 5 years | #24 |
| gene expression immunity | #24 |
| 2fold risk | #24 |
| asthma aa | #24 |
| allergic respiratory symptoms | #24 |
| contact livestock | #24 |
| eczema susceptibility | #24 |
| exposure road traffic | #24 |
| haying | #24 |
| 4 phenotypes | #24 |
| asthma cross | #24 |
| countrys | #24 |
| phenotypes childhood | #24 |
| west german | #24 |
| dust endotoxin | #24 |
| wheeze symptoms | #24 |
| asthma prevention | #24 |
| asthma early | #24 |
| children indoor | #24 |
| bronchitis child | #24 |
| doctor diagnosed | #24 |
| asthma age | #24 |
| allergic dermatitis | #24 |
| sensitization early | #25 |
| antibiotic year | #25 |
| car traffic | #25 |
| il13 pathway | #25 |
| igg1 ige | #25 |
| expression ige | #25 |
| cytokines children | #25 |
| risk atopic diseases | #25 |
| farm animals | #25 |
| 5030 | #25 |
| methods association | #25 |
| environmental determinants | #25 |
| 2 12 months | #25 |
| prevention asthma | #25 |
| exposure paracetamol | #25 |
| card4 | #26 |
| environmental asthma | #26 |
| sputum eosinophils feno | #26 |
| allergen sensitisation | #26 |
| microbiota asthma | #26 |
| early phenotypes | #26 |
| child conjunctivitis | #26 |
| wheezing childhood | #26 |
| blood samples children | #26 |
| levels mite | #26 |
| trendwise | #26 |
| increased treg | #26 |
| fev1 bhr | #26 |
| risk factors probability | #26 |
| asthma syndrome | #26 |
| early atopic | #26 |
| clinical phenotypes children | #26 |
| 5 european countries | #26 |
| 3rd year | #26 |
| farms humans | #26 |
| written questionnaire | #26 |
| risk allergic sensitization | #26 |
| prevention allergic diseases | #27 |
| npsr1 asthma | #27 |
| 035 iu | #27 |
| asthma child cross | #27 |
| wheeze childhood | #27 |
| prevalence fever | #27 |
| prevalence atopic eczema | #27 |
| asthmatic participants | #27 |
| single snps | #27 |
| allergens europe | #27 |
| visible mould | #27 |
| specific ige levels | #27 |
| respiratory infections year | #27 |
| childhood origins | #27 |
| factors year | #27 |
| asthma childhood | #27 |
| association childhood asthma | #27 |
| muramic | #27 |
| children parental asthma | #27 |
| 9 11 years | #27 |
| children asthma symptoms | #27 |
| ilt3 | #27 |
| consumption raw milk | #27 |
| asthma environmental | #27 |
| analysis lca | #28 |
| il13 polymorphisms | #28 |
| pregnancy increase | #28 |
| dust children | #28 |
| weekly diaries | #28 |
| early identification children | #28 |
| higher hrqol | #28 |
| immune phenotypes | #28 |
| gene asthma | #28 |
| east germany | #28 |
| levels sensitization | #28 |
| recurrence persistence | #28 |
| host factors infection | #28 |
| ige therapy | #28 |
| atopic phenotypes | #28 |
| childhood asthma risk | #28 |
| 10 years data | #28 |
| feno fev1 | #28 |
| women males | #29 |
| preschool environmental | #29 |
| dust indoor | #29 |
| acinetobacter lwoffii | #29 |
| enhanced expression genes | #29 |
| primary prevention asthma | #29 |
| early years life | #29 |
| farming | #29 |
| bioair | #29 |
| pediatric asthma patients | #29 |
| pblc | #29 |
| polymorphisms identified | #29 |
| anthroposophy | #29 |
| polymorphisms il13 | #29 |
| questionnaires urban | #29 |
| vivo age | #29 |
| centers prevalence | #29 |
| rad50 gene | #29 |
| adult agriculture | #29 |
| mite sensitization | #29 |
| viral infections asthma | #30 |
| affluent | #30 |
| dismutase 3 | #30 |
| asthma childhood asthma | #30 |
| il10 snps | #30 |
| incidence recurrence | #30 |
| effective ways | #30 |
| boys asthma | #30 |
| biodiversity child | #30 |
| probability persistence | #31 |
| atopy children | #31 |
| moisture damage | #31 |
| centres countries | #31 |
| bronchial obstruction | #31 |
| childhood infectious | #31 |
| asthma atopic | #31 |
| persons european ancestry | #31 |
| enhancer marks | #31 |
| traditional farming | #31 |
| children diagnosed asthma | #31 |
| ribosomal preschool dna | #31 |
| il10 polymorphisms | #31 |
| card4 nod1 | #31 |
| questionnaires asthma | #31 |
| atopic food | #31 |
| atopic diseases | #32 |
| susceptibility asthma | #32 |
| symptoms childhood | #32 |
| association paracetamol | #32 |
| linked polymorphisms | #32 |
| asthma odds ratio | #32 |
| rural regions | #32 |
| microbial environments | #32 |
| obese children age | #32 |
| r2447x | #32 |
| gata3 gene | #32 |
| epidemiology asthma | #32 |
| doctordiagnosed | #32 |
| disease childhood | #32 |
| preschool day | #32 |
| living environments | #32 |
| huge burden | #32 |
| européens | #32 |
| allergic diseases age | #32 |
| transferase deficiency | #32 |
| studies dermatitis | #32 |
| germany leipzig | #32 |
| prick tests | #32 |
| african ancestry asthma | #32 |
| cohorts asthma | #32 |
| infants countries | #32 |
| microbial components | #32 |
| multiancestry association | #33 |
| bhr fev1 | #33 |
| allergic genetic epigenesis | #33 |
| imputation data | #33 |
| eczema prevalence | #33 |
| immune cell enhancer | #33 |
| genetic epigenesis allergic | #33 |
| multiancestry association study | #33 |
| asthma associations loci | #33 |
| specificity skin tests | #33 |
| pregnancy maternal health | #34 |
| endotoxins environmental | #34 |
| dust microbiota | #34 |
| curve asthma | #34 |
| mite allergen exposure | #34 |
| participants questionnaire | #34 |
| indoor mould | #34 |
| year life | #34 |
| health utilization children | #34 |
| new onset symptoms | #34 |
| studies dust | #34 |
| asthma atopic eczema | #34 |
| pattern frequency | #34 |
| bacterial farms | #34 |
| bradykinin receptor gene | #34 |
| fascinating | #34 |
| asthma risk children | #34 |
| infant contact | #34 |
| tests surveys | #34 |
| participants childhood | #34 |
| development atopy | #34 |
| clec4e | #34 |
| nonatopic mothers | #35 |
| risk asthma | #35 |
| feno lung function | #35 |
| endotoxin levels | #35 |
| western germany | #35 |
| preschool fatty acids | #35 |
| asthma conjunctivitis | #35 |
| children cross | #35 |
| diseases rhinitis | #35 |
| raw cows milk | #35 |
| urbanrural differences | #35 |
| prick testing | #35 |
| western lifestyle | #35 |
| germany haplotypes | #35 |
| 95 atopic dermatitis | #35 |
| wingedhelix | #35 |
| asthma asthma phenotypes | #35 |
| anthroposophic | #35 |
| tagging polymorphisms | #35 |
| farms female | #35 |
| analysis steps | #35 |
| tolerance biomarkers | #36 |
| maternal vitamin intake | #36 |
| maternal exposures | #36 |
| leipzig | #36 |
| prevalence childhood asthma | #36 |
| 1 stimulation | #36 |
| asthma dendritic cells | #36 |
| exposure genetic | #36 |
| chapter 1 epidemiology | #36 |
| skin test reactivity | #36 |
| 16s rrna data | #36 |
| native milk | #37 |
| asthma candidate | #37 |
| ril33 | #37 |
| incidence persistence | #37 |
| nasal samples | #37 |
| 8263 | #37 |
| lifestyle environment | #37 |
| allemagne | #37 |
| earlylife exposures | #37 |
| case status | #37 |
| mouse model asthma | #38 |
| foxp3 levels | #38 |
| life increased | #38 |
| eczema environmental | #38 |
| recurrence risk factors | #38 |
| reverse causation | #38 |
| asthma allergens | #38 |
| endotoxin asthma | #38 |
| development allergic | #38 |
| maximum expiratory flow | #38 |
| allergy birth | #38 |
| itchy | #38 |
| dust asthma | #38 |
| atopy prevalence | #38 |
| asthma cough | #38 |
| ormdl3 expression | #38 |
| association ndvi | #38 |
| nps npsr1 | #38 |
| wisc | #38 |
| amish | #38 |
| innate immunity genes | #38 |
| ige switching | #39 |
| levels house | #39 |
| haploview | #39 |
| protect children | #39 |
| traffic asthma | #39 |
| wheezing phenotypes | #39 |
| adulthood risk factors | #39 |
| genetic rhinitis | #39 |
| c589 | #39 |
| maternal health pregnancy | #39 |
| allergic symptoms children | #39 |
| igg nglycosylation | #39 |
| degradation patients | #39 |
| polymorphisms asthma | #39 |
| seasonal perennial | #39 |
| diversity environmental | #39 |
| antibiotics development | #40 |
| 4606 | #40 |
| mite exposure | #40 |
| preschool conjunctivitis | #40 |
| biodiversity health | #40 |
| symptoms allergic | #40 |
| transcription 6 | #40 |
| eczema | #40 |
| isolated polysaccharides | #40 |
| animal farms | #40 |
| children bronchial | #40 |
| crosssectional studies | #40 |
| treg cells patients | #41 |
| risk factors health | #41 |
| small airway dysfunction | #41 |
| farm residence | #41 |
| stress young | #41 |
| asthma wheeze | #41 |
| eczema phenotypes | #41 |
| discotheques | #41 |
| german cities | #41 |
| allergic child | #41 |
| allergens age | #41 |
| effects asthma | #41 |
| polymorphism single nucleotide | #42 |
| international patterns | #42 |
| 95 antibiotics | #42 |
| microbiome data | #42 |
| dust female | #42 |
| food questionnaire | #42 |
| onset year | #42 |
| pcdh1 | #42 |
| bronchiale | #42 |
| asthma onset | #43 |
| time asthma | #43 |
| increased regulatory | #43 |
| sensitized subjects | #43 |
| worldwide variations | #43 |
| treg th17 cells | #43 |
| dermatitis food | #43 |
| asthma food | #43 |
| subspecies infantis | #43 |
| wide variations | #44 |
| national institute allergy | #44 |
| cells cord | #44 |
| facklamia | #44 |
| diseases childhood | #44 |
| followup physical activity | #44 |
| asthma cystic fibrosis | #44 |
| atopic diseases asthma | #44 |
| increased risk symptoms | #44 |
| atp2a3 | #44 |
| asthma food allergy | #44 |
| prevalence symptoms | #44 |
| gsdma | #44 |
| sequential switching | #44 |
| microbiome asthma | #44 |
| work overload | #44 |
| early childhood infections | #44 |
| 97th | #44 |
| developing countries children | #44 |
| bamse | #45 |
| animals pregnancy | #45 |
| exposure early life | #45 |
| severe atopic eczema | #45 |
| 7445 | #45 |
| phenotype respiratory | #45 |
| biodiversity hypothesis | #45 |
| traffic exposure | #45 |
| questionnaire responses | #45 |
| birth 12 months | #45 |
| sensitization inhalant | #45 |
| antiasthma drugs | #45 |
| fever 95 | #45 |
| dust endotoxins | #45 |
| atopic diseases children | #46 |
| adolescence differences | #46 |
| evidence gene | #46 |
| prevalence current wheeze | #46 |
| improvement reduction | #46 |
| control physical | #46 |
| spt reactivity | #46 |
| receptor tolllike receptors | #46 |
| prevalence diseases | #46 |
| asthma cluster | #46 |
| prevalence bhr | #46 |
| farm animal | #46 |
| humans hygiene | #46 |
| asthma gwas | #46 |
| international study | #47 |
| analysis step | #47 |
| tirana | #47 |
| germany east | #47 |
| wheeze phenotypes | #47 |
| efraim | #47 |
| children atopic disease | #47 |
| 95 eczema | #47 |
| factors asthma | #47 |
| franche | #47 |
| prevalence rhinoconjunctivitis | #47 |
| asthma biological | #48 |
| airways diseases | #48 |
| cluster children | #48 |
| halle | #48 |
| frequent wheeze | #48 |
| asthma risk loci | #48 |
| wheeze age | #48 |
| doctordiagnosed asthma | #48 |
| asthma adjusted | #48 |
| lung function spirometry | #48 |
| breath volatile | #48 |
| prevalences asthma | #48 |
| polymorphisms il4 | #48 |
| fungal flora | #48 |
| perennial allergens | #48 |
| parental interviews | #48 |
| chromosome susceptibility | #49 |
| children paracetamol | #49 |
| n228 | #49 |
| children female humans | #49 |
| milk farm | #49 |
| risk factors incidence | #49 |
| fcer1a | #49 |
| longum subsp infantis | #50 |
| background atopic | #50 |
| pcrsscp | #50 |
| bacterial markers | #50 |
| diversity food | #50 |
| physiciandiagnosed | #50 |
| unpasteurized milk | #50 |
| exposures asthma | #50 |
| beta13glucans | #50 |
| association allergic | #51 |
| igg1 igg4 | #51 |
| allergy symptoms | #51 |
| identified polymorphisms | #51 |
| country prevalence | #51 |
| populationattributable risk | #51 |
| maintenant | #51 |
| common chronic disease | #51 |
| asthma maternal | #51 |
| asthma dust | #51 |
| conjugated mice mice | #51 |
| microbial burden | #51 |
| association atopic dermatitis | #51 |
| lwoffii | #51 |
| children cities | #51 |
| gpra | #52 |
| specific protective | #52 |
| epidemiologischen | #52 |
| 9357 | #52 |
| age wheezing | #52 |
| wheeze cough | #52 |
| ige sige | #52 |
| sensitization children | #52 |
| doctor diagnosis | #52 |
| itchy rash | #52 |
| geneenvironment interactions | #52 |
| indoor endotoxin | #52 |
| infant study | #52 |
| eczema childhood | #52 |
| bmi asthma | #52 |
| prevalence wheeze | #52 |
| milk consumption | #52 |
| outdoor pollution | #53 |
| il13 gene | #53 |
| children current asthma | #53 |
| 2q32 | #53 |
| adam33 asthma | #53 |
| life exposure | #53 |
| ige children | #53 |
| atopic eczema children | #53 |
| early life exposure | #53 |
| estonian children | #54 |
| prevalence wheezing | #54 |
| female germany life | #54 |
| asthma odds | #54 |
| animals asthma | #54 |
| male prevalence | #54 |
| nonmicrobial | #54 |
| cross sectional studies | #54 |
| stepwise procedure | #55 |
| samples farm | #55 |
| bacterial microbiota | #55 |
| prevalence association | #55 |
| cough wheeze | #55 |
| year asthma | #55 |
| immunoglobulin interleukin13 | #56 |
| random samples | #56 |
| tuberculosis notification | #56 |
| adult asthma patients | #56 |
| visible mold | #56 |
| alex study | #56 |
| atopy development | #56 |
| maternal ige | #56 |
| strong protective | #56 |
| asthma atopy | #56 |
| cd14 tolllike receptor | #56 |
| life atopic dermatitis | #57 |
| atopy wheeze | #57 |
| 3785 | #57 |
| member 1 polymorphism | #57 |
| pollutant exposure | #57 |
| mef50 | #57 |
| prevention allergic | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| derp1 | #57 |
| mononuclear lipid | #57 |
| adam33 polymorphisms | #57 |
| eczema flg | #57 |
| diseases methods | #57 |
| total serum | #58 |
| specificity asthma | #58 |
| diseases children | #58 |
| stat6 gene | #58 |
| hypersensitivity immunoglobulin | #58 |
| reported parents | #58 |
| eczema female | #58 |
| early asthma | #58 |
| german participants | #59 |
| th17 lineage | #59 |
| asthma morbidity children | #59 |
| 6 years age | #59 |
| finland estonia | #59 |
| 1q31 | #59 |
| farm families | #59 |
| milk cla | #59 |
| rna yield | #60 |
| beta 2agonists | #60 |
| allergic surveys | #60 |
| birth school age | #60 |
| preschool wheezing | #60 |
| predictors incidence | #60 |
| development childhood | #60 |
| iedap | #60 |
| implicated genes | #61 |
| species colonization | #61 |
| atopy eczema | #61 |
| seasonal skin tests | #61 |
| breastfed children | #61 |
| exposure asthma | #61 |
| estonia finland | #62 |
| childhoodonset asthma | #62 |
| life immune | #62 |
| asthma birth | #62 |
| respiratory sounds | #62 |
| development airway hyperresponsiveness | #62 |
| large german | #62 |
| immunoglobulin infant | #62 |
| persistence asthma | #62 |
| endotoxin level | #63 |
| dermatitis risk | #63 |
| total quantity | #63 |
| children role | #63 |
| indoor allergen exposure | #63 |
| cystic fibrosis abpa | #63 |
| children regions | #63 |
| asthma breast | #63 |
| exposure assessed | #63 |
| hyperreactivity bronchial | #63 |
| atopic | #63 |
| children centers | #64 |
| differential networks | #64 |
| dust parameters | #64 |
| allergenspecific ige | #64 |
| helminth ascariasis ascaris | #64 |
| no2 benzene | #64 |
| newborn lymphocyte | #64 |
| childhood allergic diseases | #65 |
| animal contact | #65 |
| healthy controls children | #65 |
| risk wheezing | #65 |
| sensitization allergic | #66 |
| preschool haemophilus humans | #66 |
| atopic symptoms | #66 |
| prevalence current asthma | #66 |
| ga²len | #66 |
| living area | #66 |
| immunological data | #66 |
| dust extracts | #66 |
| allergic rhinitis age | #66 |
| umc | #66 |
| ige expression | #67 |
| 2 questionnaires | #67 |
| biomarkers predictors | #67 |
| respiratory allergies | #67 |
| maternal atopy | #67 |
| pa obesity | #67 |
| early wheeze | #68 |
| mère | #68 |
| antibiotic sales | #68 |
| weight boys | #68 |
| ige allergens | #69 |
| suisse | #70 |
| hypersensitivity immunization | #70 |
| atopic disease children | #70 |
| gene gene interaction | #70 |
| sod3 | #70 |
| asthma complex | #70 |
| allergic disorders | #70 |
| barns | #71 |
| prenatal vitamin | #71 |
| tlr2 tlr1 | #71 |
| atopic rhinitis | #71 |
| occurrence progression | #71 |
| breathomics | #71 |
| small airway function | #71 |
| allergic sensitization children | #71 |
| unprocessed | #71 |
| persistent asthma children | #72 |
| children wheeze | #72 |
| infantis | #72 |
| factor asthma | #72 |
| 158 95 | #72 |
| molecular fingerprinting | #72 |
| association occupational exposure | #72 |
| ormdl3 | #73 |
| european ancestry association | #73 |
| gni | #73 |
| sounds respiratory | #73 |
| onset allergic | #73 |
| food allergy asthma | #74 |
| risk wheeze | #74 |
| exposure europe | #74 |
| severe eczema | #74 |
| west humans | #74 |
| health services children | #74 |
| rfel | #75 |
| chromosome 17q21 | #75 |
| total serum ige | #75 |
| children hrqol | #75 |
| asthmatic mothers | #75 |
| maternal immunity | #75 |
| standardized procedure | #75 |
| asthma genome | #75 |
| wheezing | #76 |
| asthma case | #76 |
| rural differences | #76 |
| symptoms eczema | #76 |
| eczema children | #76 |
| food inhalant | #76 |
| allergy childhood | #76 |
| microbial molecules | #76 |
| 9 mmp9 | #77 |
| sexspecific association | #77 |
| asthma healthy | #77 |
| diversity microbial | #77 |
| hyperresponsiveness bhr | #77 |
| years odds | #78 |
| 6399 | #78 |
| blood cytokines | #78 |
| mothers asthma | #78 |
| turkish origin | #78 |
| findings prevalence | #78 |
| rhinitis atopic | #78 |
| edta tubes | #78 |
| sensitisation children | #78 |
| childhood | #78 |
| wheezing illnesses | #78 |
| interactions snps | #79 |
| seasonal asthma | #79 |
| neuropeptide receptor | #79 |
| genes innate immunity | #79 |
| 95 protection | #79 |
| milk yoghurt | #79 |
| cats child | #80 |
| dander | #80 |
| ige skin | #80 |
| lower prevalence | #81 |
| microbial agents | #81 |
| symptoms 12 | #81 |
| development atopic dermatitis | #81 |
| childhood wheeze | #81 |
| forkhead box protein | #81 |
| prevalence respiratory | #81 |
| bacterial viral infections | #82 |
| age 45 | #82 |
| 13 14 | #82 |
| concentrations so2 | #82 |
| ribosomal pcr | #82 |
| age prevalence | #82 |
| children european | #82 |
| laryngitis | #82 |
| introduction solids | #82 |
| study pcr | #83 |
| gut commensals | #83 |
| microbial stimulation | #83 |
| cleanliness | #83 |
| study population patients | #83 |
| current wheezing | #83 |
| hypersensitivity risk | #83 |
| total fat content | #83 |
| children siblings | #83 |
| reporter genetic predisposition | #83 |
| control pa | #84 |
| specific exposures | #84 |
| oligoarticular juvenile | #84 |
| 4732 | #84 |
| new asthma | #84 |
| tests child | #84 |
| single nucleotide rna | #85 |
| α1 antitrypsin | #85 |
| n134 | #85 |
| atopy risk | #85 |
| européenne | #85 |
| bronchial responsiveness | #85 |
| infant inflammation | #86 |
| ige levels | #86 |
| arabinogalactan | #86 |
| comté | #86 |
| children feeding | #86 |
| wheeze prevalence | #86 |
| hyper responsiveness | #86 |
| bifidobacterium species | #86 |
| truck traffic | #86 |
| influential factors | #87 |
| analysis respiratory | #87 |
| visits asthma | #87 |
| genes asthma | #87 |
| 95 fever | #87 |
| exposure associations | #87 |
| age asthma | #87 |
| pollution allergens | #88 |
| tolllike receptors tlrs | #88 |
| exposure tobacco smoke | #88 |
| rhinitis risk | #88 |
| allergy tests | #88 |
| asthma polymorphisms | #88 |
| asthma children | #89 |
| aged 6 | #89 |
| bronchial hyper | #89 |
| asthma phenotypes | #89 |
| rphl | #89 |
| critical time window | #90 |
| children area | #90 |
| current exposure | #90 |
| allergic seasonal surveys | #90 |
| development eczema | #91 |
| newborn leukocytes | #91 |
| newborn limit | #91 |
| asthma school | #91 |
| joint workshop | #91 |
| filaggrin mutations | #91 |
| mononuclear polymorphism | #92 |
| sensitisation | #92 |
| geführt | #93 |
| previous studies association | #93 |
| allergic rhinitis symptoms | #93 |
| low levels exposure | #93 |
| experimental asthma | #93 |
| south germany | #93 |
| east west germany | #93 |
| preschool haemophilus | #93 |
| rs2305480 | #93 |
| tregulatory cells | #94 |
| pertussis infection | #94 |
| zpbp2 | #94 |
| eczema symptoms | #95 |
| asthma common | #95 |
| greater consumption | #95 |
| international variation | #95 |
| asthma loci | #95 |
| university life | #95 |
| 16q12 | #95 |
| fed children | #95 |
| expression toll | #95 |
| nickel allergy | #95 |
| lps recognition | #96 |
| allergic sensitisation | #96 |
| dust environmental | #96 |
| cumulative prevalence | #96 |
| airway dysfunction | #96 |
| anaphylaxie | #96 |
| trigger factors | #96 |
| dysbalance | #96 |
| expression th1 | #96 |
| onset wheeze | #96 |
| nonfarmers | #96 |
| inhalant allergens | #97 |
| schoolchildren aged | #97 |
| 95 overweight | #97 |
| regulatory treg | #97 |
| indoor factors | #97 |
| city air | #97 |
| age 3 years | #98 |
| background asthma | #98 |
| factors school | #98 |
| childhood adulthood | #98 |
| tlr1 tlr2 | #98 |
| children germany | #98 |
| seasonal sensitivity | #98 |
| current wheeze | #99 |
| comprehensive questionnaire | #99 |
| asthma inflammation | #99 |
| children atopic | #99 |
| seasonal surveys | #99 |
| rural school | #99 |
| years aor | #99 |
| eastern germany | #99 |
| earlyonset asthma | #99 |
| childhood atopic dermatitis | #100 |
| isaac questionnaire | #100 |
| preschool crosssectional studies | #100 |
| summarised | #101 |
| weight girls | #101 |
| expression measurements | #101 |
| genetic factors susceptibility | #101 |
| mef25 | #101 |
| raw cow | #101 |
| tenascin tnc | #102 |
| effects respiratory | #102 |
| factors wheezing | #102 |
| ige concentrations | #102 |
| risk factors persistence | #102 |
| retinoid acid | #102 |
| years early | #103 |
| hdm exposure | #103 |
| sensitization eczema | #103 |
| irf1 gene | #103 |
| children increased risk | #103 |
| 4264 | #103 |
| exposure milk | #104 |
| sensitization childhood | #104 |
| children relation | #104 |
| arabinogalactans | #105 |
| pollen concentration | #105 |
| high‐sensitivity | #105 |
| hutterites | #105 |
| hyperreactivity | #105 |
| animal dander | #106 |
| children contact | #106 |
| physiciandiagnosed asthma | #106 |
| wheezing disorders | #106 |
| questionnaires switzerland | #106 |
| blood ige | #106 |
| prevalence atopy | #106 |
| puberty age | #107 |
| underlying factor | #107 |
| socs4 | #107 |
| detailed questionnaire | #107 |
| overweight 95 | #108 |
| inverse associations | #108 |
| breast feeding | #108 |
| fever episodes | #108 |
| healthy children children | #109 |
| moulds | #109 |
| air pollution children | #109 |
| allergic perennial rhinitis | #109 |
| publication air pollution | #109 |
| complex syndrome | #109 |
| asthma wheezing | #109 |
| p≤003 | #110 |
| atopic eczema humans | #110 |
| rs7216389 | #110 |
| folgenden | #110 |
| genotype germany | #110 |
| female germany | #110 |
| parental questionnaire | #111 |
| il4ra | #111 |
| environmental study | #112 |
| female histones | #112 |
| 1314 | #112 |
| tbox transcription factor | #112 |
| olive pollen | #112 |
| milk samples | #112 |
| experimental allergic asthma | #113 |
| risk allergic | #113 |
| flg variants | #113 |
| allergic | #113 |
| phenotypes asthma | #113 |
| indoor asthma | #113 |
| parent reported | #114 |
| allergic disease | #114 |
| occupational allergy | #114 |
| mould exposure | #114 |
| tests bronchial | #114 |
| asthma sensitization | #114 |
| challenge data | #114 |
| notification rates | #115 |
| igg4 responses | #115 |
| foxp3 locus | #115 |
| increased diversity | #115 |
| cough children | #115 |
| cord blood ige | #115 |
| exclusive breast feeding | #116 |
| aged 9 | #116 |
| immune responsiveness | #116 |
| regulatory th17 | #116 |
| psychosocial characteristics | #117 |
| children underwent | #117 |
| glutathione transferase gst | #117 |
| germany humans | #118 |
| skinprick tests | #118 |
| west germany | #118 |
| allergic sensitization | #118 |
| ratio prevalence | #118 |
| reference children | #118 |
| living rural | #118 |
| indoor microbial | #118 |
| children wheezing | #119 |
| delayed introduction | #119 |
| ancestry asthma | #119 |
| switching immunoglobulin | #119 |
| skin prick | #119 |
| environment children | #120 |
| association chromosome | #120 |
| levels endotoxin | #120 |
| fibrolysis | #120 |
| childhood risk factors | #120 |
| symptom control | #121 |
| factors rural | #121 |
| allergens asthma | #121 |
| common aeroallergens | #121 |
| lung function measurements | #121 |
| vitamin supplementation pregnancy | #121 |
| aliments | #121 |
| dampness | #121 |
| 300 people | #122 |
| tlr10 | #122 |
| life early | #122 |
| preventive potential | #122 |
| hayfever | #123 |
| frequency pattern | #123 |
| urban traffic | #123 |
| atopic manifestations | #124 |
| severe eosinophilic asthma | #124 |
| passive smoke exposure | #124 |
| germany prevalence | #124 |
| active asthma | #124 |
| common inhalant | #125 |
| immunologic tolllike receptor | #125 |
| potted plants | #125 |
| il18r1 | #125 |
| prevalence allergic diseases | #126 |
| 3 infections | #126 |
| asthma background | #126 |
| paediatric studies | #126 |
| effects prevalence | #126 |
| eczema patients | #126 |
| await | #126 |
| sensitization development | #126 |
| exposure pets | #126 |
| allergens child | #127 |
| adaptive cells | #127 |
| exposure endotoxin | #127 |
| test reactivity | #127 |
| prävalenz | #127 |
| 95 ors | #127 |
| environmental allergens | #127 |
| parent questionnaire | #127 |
| caspase recruitment domain | #127 |
| bdnf polymorphisms | #128 |
| receptors male | #129 |
| bdnf gene | #129 |
| microbial markers | #129 |
| medall | #130 |
| hypersensitivity respiratory | #131 |
| asthma objective | #131 |
| sensitization allergens | #131 |
| protein allergy | #131 |
| factors allergens | #131 |
| severe eosinophilic | #131 |
| respiratory symptoms children | #131 |
| common allergens | #131 |
| test study | #131 |
| immunoglobulin inflammation | #132 |
| asthma adolescent | #132 |
| effects development | #132 |
| expression receptors | #132 |
| male occupational | #132 |
| diseases asthma | #132 |
| bavaria | #133 |
| understanding natural | #133 |
| pollen prevalence | #133 |
| age 7 | #133 |
| early age | #133 |
| allergy | #134 |
| 7 years age | #134 |
| dpp10 | #134 |
| body composition bmi | #135 |
| prevalence rhinitis | #135 |
| crth2 | #135 |
| childhood risk | #135 |
| 95 ages | #135 |
| bronchial response | #136 |
| asthma young | #136 |
| eczema risk | #136 |
| 60 iu | #136 |
| allergic phenotype | #136 |
| ms4a2 | #137 |
| actinomycetes | #137 |
| snps asthma | #137 |
| 6 7 | #137 |
| mechanisms asthma | #137 |
| exposure children | #137 |
| ga2len | #137 |
| asthma development | #138 |
| régions | #138 |
| pollutants allergens | #138 |
| sensitized children | #138 |
| asthma atopic dermatitis | #138 |
| mattress | #138 |
| snps interactions | #138 |
| reduced prevalence | #138 |
| serum ige | #139 |
| allergen levels | #139 |
| 3 14 | #139 |
| sebacate | #139 |
| pollution asthma | #139 |
| listeria spp | #139 |
| milk animals | #139 |
| tregs foxp3 | #140 |
| pasture | #140 |
| microbiota children | #140 |
| largest reduction | #140 |
| exposure symptoms | #140 |
| duration type | #140 |
| asthma genes | #141 |
| exposure indoor | #141 |
| age 6 years | #141 |
| susceptibility children | #142 |
| indoor allergens | #142 |
| n183 | #142 |
| questionnaires illness surveys | #142 |
| factors difference | #142 |
| asthma bronchitis | #142 |
| cla content | #142 |
| pregnancy early | #143 |
| unifrac | #143 |
| inconclusive | #144 |
| incident asthma | #144 |
| snps chromosome | #144 |
| exposure year | #144 |
| asthma defined | #144 |
| replication association | #144 |
| pet exposure | #144 |
| onset menarche | #145 |
| children allergy | #145 |
| expositions | #145 |
| dermatitis asthma | #145 |
| health outcomes children | #146 |
| allergy testing | #146 |
| prematurely born children | #146 |
| airway mechanics | #146 |
| interleukin13 interleukin4 | #146 |
| lower airways | #146 |
| prevalence skin | #146 |
| biomarkers child | #147 |
| original article | #147 |
| study centers | #147 |
| germany west | #148 |
| association early | #148 |
| children 6 | #148 |
| feno patients | #148 |
| indoor allergen | #149 |
| atopic outcomes | #149 |
| early immune | #149 |
| perennial rhinitis allergic | #150 |
| pregnancy respiratory | #150 |
| fall fev1 | #150 |
| prevalence childhood | #151 |
| wheeze children | #151 |
| profound differences | #151 |
| wheezing children | #151 |
| 105 years | #151 |
| confer protection | #151 |
| established asthma | #152 |
| environmental exposure | #152 |
| consumption dairy products | #152 |
| distribution asthma | #152 |
| exposure increased | #152 |
| bhr | #152 |
| children review | #152 |
| immunomodulatory molecules | #152 |
| wheeze asthma | #153 |
| tagging single | #153 |
| common respiratory | #153 |
| function measurements | #153 |
| asthma dermatitis | #153 |
| hens egg | #153 |
| hormonal factors | #154 |
| cd28null | #154 |
| onset association | #155 |
| neighboring countries | #155 |
| tests sex factors | #155 |
| bronchial challenge | #155 |
| association asthma | #156 |
| atopic children | #156 |
| severity frequency | #157 |
| development allergy | #157 |
| positive spt | #157 |
| gene 3 | #157 |
| absolute levels | #157 |
| neu5gc | #157 |
| early environmental | #158 |
| bacterial lysates | #158 |
| asthma females | #158 |
| lower diversity | #158 |
| paediatric asthma | #158 |
| children asthma | #159 |
| patients controlled asthma | #159 |
| developing immune | #159 |
| prevention allergy | #159 |
| children rhinitis | #160 |
| children homes | #160 |
| spts | #160 |
| allergic seasonal | #160 |
| reported prevalence | #160 |
| microbiome diversity | #160 |
| german adults | #160 |
| newborn longitudinal | #161 |
| atopy asthma | #161 |
| asthma presence | #161 |
| wheeze rhinitis | #161 |
| preventive measure | #161 |
| female humans allergic | #162 |
| immune pathways | #162 |
| children lower | #162 |
| parental asthma | #162 |
| exposure prevalence | #163 |
| perennial rhinitis | #163 |
| specific ige | #163 |
| environmental associations | #163 |
| sensitised | #164 |
| kindl | #164 |
| sscp | #164 |
| atopic eczema | #165 |
| asthma ige | #165 |
| children sensitized | #165 |
| atopic dermatitis | #165 |
| illness surveys questionnaires | #166 |
| infant respiratory | #166 |
| epidemiologie | #166 |
| ige asthma | #166 |
| 5q31 | #166 |
| feeding child | #166 |
| disease life | #167 |
| adolescent allergens | #167 |
| preschool cross | #167 |
| studies exposure | #167 |
| air pollutant concentrations | #167 |
| preadolescent children | #167 |
| years lung | #168 |
| year children | #168 |
| current asthma | #168 |
| airway size | #169 |
| 2688 | #169 |
| regulatory treg cells | #169 |
| stratification patients | #169 |
| workplace young | #169 |
| chronic inflammatory disease | #170 |
| adolescent analysis | #171 |
| nucleotide rna | #171 |
| aged 13 | #171 |
| inhalant | #171 |
| sensitization pollen | #171 |
| endotoxins female | #172 |
| ifnγ levels | #172 |
| studien | #172 |
| sheds | #172 |
| skin prick test | #172 |
| nucleotide pregnancy | #172 |
| prevalence current | #172 |
| risk score model | #173 |
| unifying concept | #173 |
| risk atopy | #174 |
| antipyretics | #174 |
| patients nocturnal | #175 |
| small airway | #175 |
| female humans questionnaires | #175 |
| mice asthma | #175 |
| repeated infections | #176 |
| serine protease inhibitor | #176 |
| sensitization common | #176 |
| school level | #176 |
| asthma attack | #176 |
| sensitization pattern | #177 |
| situ hybridization infant | #177 |
| wheezers | #177 |
| life respiratory function | #177 |
| aa patients | #178 |
| genetic severity | #178 |
| 9p24 | #178 |
| sensitization asthma | #178 |
| childhood infections | #178 |
| traffic characteristics | #179 |
| w12 | #179 |
| studies environmental | #179 |
| sputum neutrophils | #179 |
| childhood adolescence | #179 |
| standardized methodology | #179 |
| objective measurements | #179 |
| nocturnal asthma | #179 |
| breastfed infant | #180 |
| asthma genetic | #180 |
| socks | #180 |
| mattresses | #181 |
| lung function testing | #181 |
| children environmental | #181 |
| environmental predictors | #181 |
| bacterial count | #181 |
| differences hrqol | #182 |
| dust levels | #182 |
| vitamin asthma | #182 |
| immunemediated diseases | #182 |
| dermatitis children | #182 |
| mögliche | #183 |
| tlr signaling | #183 |
| exposure humans | #183 |
| vocational training | #183 |
| children levels | #183 |
| german population | #183 |
| environmental microbiology | #183 |
| incidence allergic | #185 |
| school district | #185 |
| life prevalence | #185 |
| work asthma | #186 |
| protein child | #187 |
| environmental exposures | #188 |
| development allergic disease | #188 |
| childhood early adulthood | #188 |
| selfselection | #188 |
| tests children | #188 |
| asthma body | #188 |
| qpcrs | #188 |
| jf1 | #189 |
| tlr genes | #189 |
| wheezing age | #190 |
| inversely | #190 |
| early wheezing | #190 |
| bacterial groups | #190 |
| muscle mass patients | #190 |
| mother pregnancy | #190 |
| association antibiotic | #190 |
| type duration | #190 |
| blood gene | #191 |
| cd14 gene | #191 |
| atopic dermatitis children | #191 |
| dry cough | #191 |
| longum subsp | #192 |
| pyroglyphidae | #192 |
| adjusted irr | #192 |
| cε | #193 |
| adam33 | #193 |
| milk serum | #193 |
| model allergic | #193 |
| eosinophilic asthma | #195 |
| prevalence severity | #195 |
| estonian | #195 |
| caspase recruitment | #196 |
| enthusiasm | #197 |
| review asthma | #197 |
| germany switzerland | #197 |
| questionnaire data | #198 |
| earlylife | #198 |
| rhinitis eczema | #199 |
| decreased prevalence | #199 |
| representative population | #199 |
| upper lower airways | #200 |
| bacteria role | #202 |
| allergy infectious diseases | #202 |
| complex interplay | #202 |
| patients europe | #203 |
| paediatrician | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| difference prevalence | #204 |
| patients aa | #204 |
| phenotyped | #204 |
| new locus | #205 |
| dermatitis atopic | #205 |
| 13 years age | #205 |
| amebocyte | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| asthma respiratory symptoms | #207 |
| asthma methods | #207 |
| factors atopy | #207 |
| allergic asthmatics | #208 |
| studies germany | #208 |
| male phenotype | #208 |
| diagnosed asthma | #208 |
| karelia | #208 |
| glycolylneuraminic acid | #209 |
| higher diversity | #209 |
| innate adaptive immunity | #209 |
| col4a3 | #209 |
| studies cytokines | #209 |
| prevalence obesity | #209 |
| newborn logistic | #209 |
| sensitization age | #209 |
| bhr asthma | #210 |
| epithelial barrier function | #210 |
| symptoms children | #210 |
| core microbiome | #210 |
| bronchial provocation | #210 |
| low prevalence | #211 |
| influence development | #211 |
| cats dogs | #211 |
| exposure sensitization | #211 |
| tlr4 cd14 | #212 |
| birth 6 | #212 |
| asthma animals | #212 |
| atopic dermatitis asthma | #212 |
| asthma allergic | #212 |
| methodssubjects | #212 |
| distinct clusters | #213 |
| exposure allergens | #213 |
| cohort methods | #213 |
| patients uncontrolled asthma | #213 |
| 1872 | #213 |
| asthma allergic diseases | #214 |
| workplace exposure | #214 |
| expression cd14 | #214 |
| reverse causality | #214 |
| 00035 | #214 |
| rural environment | #214 |
| prevalence allergic | #214 |
| life allergic | #215 |
| obesity overweight | #216 |
| mast cell chymase | #216 |
| regulatory responses | #216 |
| il2rb | #218 |
| atopic female | #218 |
| causation | #219 |
| disinfectants | #219 |
| child dna | #219 |
| geneticist | #219 |
| microbial products | #219 |
| allergy development | #220 |
| steiner | #220 |
| pierced | #220 |
| variants asthma | #220 |
| schistosoma schistosomiasis | #221 |
| homogenised | #221 |
| method participants | #221 |
| 90 children | #222 |
| increased asthma | #222 |
| sensitization rates | #222 |
| environmental epidemiology | #223 |
| symptoms baseline | #223 |
| groups asthma | #224 |
| sibship size | #225 |
| german study | #225 |
| german | #226 |
| sensitization allergen | #226 |
| conjunctivitis allergic | #226 |
| alpha1 antitrypsin | #226 |
| provocative concentration | #227 |
| school age | #227 |
| data asthma | #228 |
| lung health | #228 |
| allergic diseases asthma | #228 |
| 95 obesity | #228 |
| test spt | #228 |
| specific stimulation | #228 |
| tuberculosis prevalence | #229 |
| understanding asthma | #229 |
| road traffic | #229 |
| wheezing asthma | #229 |
| healthy worker | #229 |
| butyryl | #230 |
| umwelt | #230 |
| cord blood cells | #230 |
| asthma phenotype | #230 |
| asthma allergic rhinitis | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| living conditions | #232 |
| nonallergic asthma | #232 |
| health variables | #232 |
| subgroup children | #232 |
| 20 fall | #232 |
| discontent | #232 |
| innate leukocytes | #233 |
| lively | #233 |
| prevalence overweight | #233 |
| complementary food | #234 |
| dermatophagoides pteronyssinus | #234 |
| hyperreactive | #234 |
| fourth grade | #235 |
| n144 | #235 |
| specific allergen | #236 |
| exposure pregnancy | #236 |
| levels asthma | #236 |
| resequenced | #236 |
| puberty girls | #238 |
| finland france | #238 |
| strategies prevention | #239 |
| incidence asthma | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| age exposure | #243 |
| immune development | #243 |
| th2 immunity | #243 |
| adjusted odds ratio | #245 |
| receptor 1 | #245 |
| adaptor protein polymorphism | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| fever asthma | #247 |
| nasal microbiota | #247 |
| role development | #247 |
| prick test | #247 |
| patients healthcare | #248 |
| children analysis | #248 |
| factors allergic | #249 |
| class analysis | #249 |
| baseline incidence | #249 |
| therapy severe | #250 |
| clinical science | #250 |
| tlr2 gene | #251 |
| biological therapy | #251 |
| communism | #252 |
| china factors | #253 |
| contact animals | #253 |
| asthma symptoms | #253 |
| cold air | #253 |
| hormonal influences | #254 |
| lowgrade inflammation | #255 |
| atopic disease | #255 |
| low pa | #256 |
| h4 acetylation | #256 |
| preschool dermatitis | #256 |
| adolescent asthma | #257 |
| body mass children | #257 |
| 454pyrosequencing | #257 |
| human asthma | #257 |
| niaid | #258 |
| association expression | #258 |
| epidemiological studies | #259 |
| prediction quality | #259 |
| airborne fungi | #259 |
| 2051 | #260 |
| exposure early | #260 |
| rhinitis allergic | #260 |
| age 6 | #260 |
| life asthma | #260 |
| life symptoms | #260 |
| discriminate | #261 |
| westernization | #261 |
| early life | #261 |
| eczema atopic | #261 |
| interferon expression | #262 |
| spink5 | #262 |
| utilization health services | #262 |
| development immune | #263 |
| alpha1antitrypsin | #263 |
| physician diagnosed | #263 |
| protein 15 | #263 |
| milk pregnancy | #263 |
| children associations | #264 |
| latex sensitization | #265 |
| tightly linked | #265 |
| exposure traffic | #265 |
| indoor exposures | #265 |
| increase asthma | #266 |
| nox concentrations | #266 |
| settled dust | #267 |
| early work | #267 |
| age 13 years | #267 |
| pollen sensitization | #268 |
| rhinitis | #269 |
| prick | #269 |
| fever children | #269 |
| symptom prevalence | #270 |
| allergen extracts | #270 |
| hypersensitivity immune | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| study centres | #273 |
| dipeptidyl peptidases | #273 |
| asthma control patients | #274 |
| objective markers | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| extracellular polysaccharides | #277 |
| future asthma | #277 |
| male microbiota | #277 |
| dust samples | #277 |
| increased exposure | #278 |
| study birth | #279 |
| tests allergens | #280 |
| hire | #280 |
| remedy | #280 |
| questionnaires adolescent | #281 |
| adolescent animals | #282 |
| allergies asthma | #282 |
| child dermatitis | #282 |
| 6 years | #282 |
| collection methods | #284 |
| randomeffects | #284 |
| impulse oscillometry | #284 |
| 17 children | #285 |
| population burden | #285 |
| allergic symptoms | #286 |
| cells ilc2s | #287 |
| differences asthma | #287 |
| tests respiratory | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| epidemiological surveys | #289 |
| hdms | #289 |
| pollution air | #289 |
| data normalization | #290 |
| role asthma | #290 |
| risk factors children | #290 |
| allergic manifestations | #291 |
| asthma increased | #291 |
| asthma factors | #292 |
| eczema food | #292 |
| recruitment domain | #293 |
| answered | #293 |
| environnement | #293 |
| longitudinal cohort study | #293 |
| cohort participants | #293 |
| indoor exposure | #293 |
| exposure environmental | #293 |
| allergic perennial | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| pollution respiratory | #297 |
| smoke pollution | #297 |
| global synthesis | #298 |
| bifidobacterium | #298 |
| exposure allergic | #299 |
| exposure benzene | #299 |
| nonatopic | #299 |
| paxgene | #299 |
| unification | #299 |
| obesity asthma | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| reported association | #307 |
| analysis phase | #307 |
| lumbricoides | #307 |
| antigens dermatophagoides | #308 |
| severe exacerbations | #308 |
| messenger tlymphocytes | #309 |
| neonatal immune | #309 |
| ige sensitization | #309 |
| mucosal microbiota | #309 |
| 2623 | #309 |
| exposure childhood | #309 |
| controlled asthma | #311 |
| factors early | #311 |
| atopic march | #312 |
| birth cohort studies | #312 |
| midexpiratory | #312 |
| allergy age | #313 |
| asthma inflammatory | #313 |
| skin examination | #314 |
| signal transducer activator | #314 |
| bacillus spores | #315 |
| jusqu | #315 |
| genotyping data | #315 |
| variance animals antigens | #315 |
| 2 toll | #316 |
| independent study | #316 |
| older siblings | #317 |
| pregnancy expression | #318 |
| child comorbidity | #318 |
| adjustment covariates | #318 |
| compared children | #319 |
| il5 il13 | #320 |
| bmi united states | #320 |
| fpr2 | #320 |
| mfi20 | #321 |
| chronic airway inflammation | #321 |
| moisturizer | #323 |
| children birth | #324 |
| ige responses | #325 |
| maximal expiratory | #325 |
| 2 yrs | #326 |
| stratified sample | #326 |
| airway hyperresponsiveness ahr | #326 |
| flg mutations | #327 |
| ichthyosis vulgaris | #327 |
| recurrent wheeze | #328 |
| bedrooms | #328 |
| active smoking | #328 |
| selfadministered questionnaire | #328 |
| extracellular dna | #329 |
| glycolylneuraminic | #330 |
| male milk | #330 |
| accuracy analysis | #331 |
| demethylation | #331 |
| reference equations | #331 |
| pollutant levels | #331 |
| floor dust | #331 |
| dermatophagoides asthma | #331 |
| streptococcaceae | #333 |
| asthma biomarkers | #333 |
| onset asthma | #333 |
| reduced lung function | #334 |
| upper respiratory | #334 |
| development sensitization | #334 |
| children controls | #335 |
| boluses | #336 |
| asthma china | #336 |
| 1st year | #337 |
| prevalence surveys | #337 |
| predictive risk factors | #337 |
| risk current | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| respiratory outcomes | #339 |
| risk eczema | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| adultonset asthma | #341 |
| exposure development | #341 |
| humans prevalence | #341 |
| persistent wheeze | #342 |
| filaggrin gene | #342 |
| kitchen | #342 |
| age introduction | #343 |
| nonatopic asthma | #343 |
| age 9 | #344 |
| breast fed | #345 |
| stat6 transcription | #346 |
| hypersensitivity | #346 |
| 90th | #348 |
| childhood onset | #349 |
| rates asthma | #350 |
| increasing prevalence | #350 |
| prevalence | #350 |
| exposed children | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| genetic interaction | #359 |
| purposepatients | #359 |
| kazal | #360 |
| subsequent asthma | #360 |
| regression approach | #360 |
| eurotium | #361 |
| asthma disease | #361 |
| strength association | #361 |
| children cohort | #361 |
| expression asthma | #363 |
| age 3 | #363 |
| cord blood | #363 |
| farming practices | #364 |
| allergic outcomes | #364 |
| food sensitization | #364 |
| austria germany | #365 |
| annual concentrations | #365 |
| chronic inflammatory disorders | #366 |
| children reported | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| expression tlr2 | #370 |
| earlylife exposure | #370 |
| adolescent air | #370 |
| single snp | #370 |
| austria switzerland | #371 |
| conclusionwe | #371 |
| testing procedures | #371 |
| 1159 | #371 |
| obesity prevalence | #373 |
| east west | #373 |
| time activity | #373 |
| paragraphs | #374 |
| 22 countries | #374 |
| performance accuracy | #374 |
| asthma current | #374 |
| asthmatic symptoms | #374 |
| foxp3 tregs | #375 |
| smoking asthma | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| associations exposure | #377 |
| statistical approaches | #377 |
| cows milk | #377 |
| positional cloning | #377 |
| population studies | #379 |
| parental reports | #379 |
| mite allergens | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| unifying | #384 |
| measles vaccination | #384 |
| preschool cohort studies | #384 |
| normal lung function | #385 |
| latex | #386 |
| chronic asthma | #386 |
| bronchial | #386 |
| impaired lung function | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| critical window | #391 |
| potential association | #391 |
| immunological analysis | #391 |
| haplotype analyses | #391 |
| 11 year | #392 |
| cde | #393 |
| early feeding | #394 |
| risk sensitization | #394 |
| 14 year | #394 |
| mmp9 gene | #394 |
| polymorphism gene | #395 |
| linear regressions | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| respiratory health | #399 |
| salmeterol xinafoate | #399 |
| study polymorphisms | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| regions countries | #402 |
| 2033 | #402 |
| receptor polymorphisms | #402 |
| length time | #403 |
| exposure animals | #403 |
| analysis asthma | #403 |
| plea | #404 |
| study agreement | #405 |
| timothy grass | #405 |
| allergens | #405 |
| cells asthma | #406 |
| allergen exposure | #406 |
| production ifngamma | #406 |
| childhood allergic | #407 |
| mugwort | #407 |
| 071 | #407 |
| data cohort | #409 |
| geneenvironment interaction | #409 |
| mold exposure | #410 |
| common occurrence | #411 |
| endotoxin exposure | #411 |
| living room | #411 |
| gene variations | #413 |
| blood cb | #413 |
| blood rna | #413 |
| ige synthesis | #414 |
| germany | #415 |
| facemasks | #416 |
| mite allergen | #416 |
| childhood exposure | #416 |
| house dust | #417 |
| bronchial hyperresponsiveness | #418 |
| illness asthma | #418 |
| 7 years | #418 |
| extended haplotypes | #419 |
| alimentary | #420 |
| age 2 years | #420 |
| population sample | #420 |
| halfwidth | #421 |
| prenatal factors | #421 |
| tnc | #424 |
| confers protection | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| childhood eczema | #429 |
| duration breastfeeding | #429 |
| childrens hospitals | #430 |
| tlr1 | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| 441 | #433 |
| risk overweight | #433 |
| respiratory allergic | #434 |
| specific sensitization | #434 |
| decrements | #438 |
| age odds ratio | #438 |
| allergy diagnosis | #438 |
| tobit | #438 |
| conundrum | #440 |
| asthma gene | #441 |
| annual prevalence | #441 |
| population asthma | #442 |
| inception | #443 |
| fecal microbiota | #443 |
| male odds | #443 |
| chronic inflammatory diseases | #443 |
| persisting | #444 |
| asthma effects | #444 |
| cell phenotypes | #444 |
| increase bmi | #445 |
| observed differences | #445 |
| asthma respiratory | #446 |
| specific serum | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| 033 | #450 |
| allergy food | #450 |
| adult asthmatics | #451 |
| n149 | #452 |
| associations asthma | #452 |
| including asthma | #455 |
| school entry | #456 |
| dermatophagoides farinae | #457 |
| pregnancy increased risk | #457 |
| germany health | #458 |
| provocation tests | #460 |
| mice role | #460 |
| allergic risk | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| asthma higher | #464 |
| rural health | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| opposite effects | #467 |
| postal questionnaire | #467 |
| cells innate | #467 |
| alex | #468 |
| severity asthma | #468 |
| immunocap | #468 |
| so2 concentrations | #469 |
| nod1 signaling | #470 |
| clinical asthma | #470 |
| early identification | #470 |
| microbial counts | #471 |
| exposure | #471 |
| emphasised | #471 |
| asthma rhinitis | #471 |
| fodder | #473 |
| antibiotics children | #473 |
| birth cohorts | #473 |
| 1133 | #474 |
| yrs | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| total immunoglobulin | #484 |
| asthma association | #484 |
| subphenotypes | #485 |
| children | #486 |
| immunity genes | #486 |
| atopic disorders | #486 |
| prospective birth cohort | #487 |
| phenotypes | #487 |
| potential confounding | #489 |
| exposure data | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| polymorphisms association | #495 |
| uncontrolled asthma | #495 |
| lifestyles | #496 |
| age 10 | #496 |
| children jia | #497 |
| southern germany | #497 |
| housing animal | #497 |
| phenotype polymorphism | #498 |
| individual level | #498 |
| asthma severe | #498 |
| respiratory hypersensitivity | #500 |
| omega6 fatty acids | #500 |
| birth age | #501 |
| asthma susceptibility | #503 |
| lung function children | #503 |
| sensitizations | #504 |
| tests specific | #505 |
| diet diversity | #505 |
| methods studies | #505 |
| white children | #505 |
| allergy children | #508 |
| ranks | #508 |
| childhood respiratory | #509 |
| prevalence rates | #509 |
| rna samples | #509 |
| housing humans | #510 |
| perennial | #511 |
| stimulation lps | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| children exposed | #515 |
| asthma prevalence | #515 |
| infections asthma | #516 |
| receptor tlr | #516 |
| asthma bronchiolitis | #516 |
| cities china | #516 |
| levels children | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| th2 immune | #519 |
| atopic conditions | #519 |
| haplotype association | #520 |
| eczema asthma | #522 |
| neutrophils eosinophils | #522 |
| p0041 | #523 |
| age 1 year | #523 |
| risk factors asthma | #523 |
| polymorphisms snps | #523 |
| children maternal | #523 |
| rural areas | #524 |
| time window | #524 |
| maternal vitamin | #525 |
| adolescence age | #525 |
| trans fatty acids | #526 |
| baseline participants | #528 |
| bmi increased risk | #528 |
| obesity body mass | #528 |
| blood humans | #529 |
| allergens animals | #529 |
| 117 95 | #529 |
| c‐reactive protein | #529 |
| edifice | #530 |
| persistent asthma | #530 |
| obesity smoking | #531 |
| environmental bacteria | #531 |
| protect | #532 |
| samples children | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| adolescence early adulthood | #541 |
| human microbiota | #541 |
| airway symptoms | #542 |
| immunological markers | #543 |
| pregnancy asthma | #543 |
| lipopolysaccharide receptors | #543 |
| rubella virus | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| 17q12 | #547 |
| antitrypsin alpha | #547 |
| greenness | #548 |
| oligoarticular | #549 |
| floorcoverings | #549 |
| hypersensitivity humans | #550 |
| association children | #553 |
| isotype switching | #553 |
| epidemic proportions | #553 |
| multidisciplinary study | #554 |
| lung microbiome | #554 |
| children parental | #555 |
| mental health patients | #555 |
| overweight prevalence | #556 |
| asthma status | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| blood eosinophils | #560 |
| letzten | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| inhaled steroids | #566 |
| 2 immunity | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| tripeptidyl | #570 |
| exposure matrix | #570 |
| initial observations | #570 |
| health urban | #571 |
| asthma symptom | #571 |
| levels total | #575 |
| affluence | #575 |
| diseases prevalence | #575 |
| hcs patients | #575 |
| atopic asthma | #579 |
| creactive protein levels | #579 |
| followups | #580 |
| oro | #580 |
| age controls | #581 |
| association obesity | #581 |
| flanking regions | #582 |
| asthma population | #582 |
| fdr | #582 |
| uht | #584 |
| tlr6 | #584 |
| asthma severity | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| longum | #590 |
| n63 | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| holiday | #593 |
| endotoxin concentrations | #593 |
| factors respiratory | #596 |
| gasdermin | #596 |
| il1rl1 | #596 |
| model asthma | #597 |
| total specific | #598 |
| pathogenesis asthma | #598 |
| advising | #598 |
| zeigen | #598 |
| galactosylation | #600 |
| genetic environmental | #600 |
| active immunity | #601 |
| factors humans | #602 |
| pregnancy maternal | #603 |
| 048 | #603 |
| hladqa1 | #604 |
| humans human | #604 |
| statistical analyses | #604 |
| agents asthma | #606 |
| sensitization | #606 |
| microbes | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| 2 inflammation | #610 |
| allergic rhinitis | #610 |
| infant feeding practices | #611 |
| 11–13 | #612 |
| work life | #612 |
| bolus | #612 |
| regulatory molecules | #612 |
| pollen allergens | #616 |
| albania | #619 |
| chronic stress | #619 |
| aged allergens | #619 |
| urban populations | #620 |
| arthropod proteins | #621 |
| life age | #621 |
| body plethysmography | #621 |
| deep phenotyping | #622 |
| unstimulated | #623 |
| radioallergosorbent | #623 |
| functional features | #625 |
| data prevalence | #627 |
| endotoxin | #627 |
| 779 | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| settled | #635 |
| exacerbating | #635 |
| feeding patterns | #635 |
| child asthma | #636 |
| standardized questionnaire | #637 |
| children atopic dermatitis | #637 |
| lifetime prevalence | #638 |
| igg glycosylation | #639 |
| european children | #639 |
| factors urban | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| life children | #650 |
| pets | #650 |
| health rural | #650 |
| kindern | #650 |
| participation rates | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| dermatitis allergic | #654 |
| comprehensive analysis | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| age 1 | #662 |
| latent classes | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| di2ethylhexyl | #665 |
| hygiene | #665 |
| abpa | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| central european | #672 |
| susceptibility locus | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| protective | #681 |
| female forced | #681 |
| random sample | #681 |
| dairy farm | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| recurrent wheezing | #685 |
| dietary habits | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| microbial flora | #703 |
| hypersensitivity inflammation | #703 |
| risk obesity | #703 |
| sensitization food | #703 |
| tao | #707 |
| 459 | #708 |
| dramatic increase | #708 |
| microbial interactions | #708 |
| perpetuation | #709 |
| immune activation | #709 |
| population surveys | #712 |
| immunologic tlymphocytes | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| alias | #734 |
| 95 males | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| nonasthmatic | #742 |
| fractional exhaled | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| environment interactions | #758 |
| h20 | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| edn1 | #768 |
| air trapping | #768 |
| pulmonary function tests | #769 |
| hscrp levels | #769 |
| allergists | #769 |
| hyperresponsiveness | #770 |
| pattern recognition receptors | #770 |
| blood leukocytes | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| incidence longitudinal | #773 |
| term impact | #773 |
| nucleotide receptors | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| new associations | #784 |
| studies asthma | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| nonallergic | #788 |
| factors tobacco | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| male metaanalysis | #793 |
| gis | #793 |
| children health | #794 |
| βdiversity | #795 |
| airway hyperresponsiveness | #795 |
| natural habitat | #796 |
| distinct trajectories | #796 |
| pc20 | #798 |
| personalization | #798 |
| protective effects | #799 |
| card15 | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| tenascin | #810 |
| exposure age | #810 |
| bifidobacterium longum | #810 |
| subclinical inflammation | #811 |
| pteronyssinus | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| boiled | #814 |
| initial data | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| trier | #830 |
| studies respiratory | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| rad50 | #833 |
| current analysis | #833 |
| promoter polymorphisms | #834 |
| farinae | #835 |
| snps haplotypes | #835 |
| igg4 | #835 |
| regularly | #835 |
| adolescent age | #837 |
| exhaled breath | #838 |
| cx3cr1 | #838 |
| parental smoking | #839 |
| public health problem | #839 |
| toll receptors | #839 |
| asthma bronchi | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| modifies | #845 |
| fetal blood | #845 |
| innate | #849 |
| potted | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| provocation | #856 |
| infant health | #856 |
| infant infant | #858 |
| age 5 | #861 |
| repeatedly | #861 |
| paracetamol | #862 |
| asthma lung | #864 |
| receptors tlrs | #864 |
| questionnaires young adult | #864 |
| volatile organic | #865 |
| birth cohort study | #866 |
| airway eosinophilia | #866 |
| ige | #866 |
| outdoor air pollution | #874 |
| cumulative incidence | #874 |
| latent class analysis | #875 |
| dermatitis | #878 |
| hmos | #878 |
| microbiome humans | #879 |
| 057 | #880 |
| 1940 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| 856 | #888 |
| brink | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| esl | #896 |
| asthma incidence | #896 |
| impact asthma | #900 |
| inflammation airway | #902 |
| immunoglobulin ige | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| adult asthma | #908 |
| shortness | #908 |
| microbiome composition | #910 |
| children overweight | #910 |
| microbiota development | #912 |
| complex disease | #917 |
| cow milk | #917 |
| immunity innate | #919 |
| methods cross | #920 |
| 710 | #920 |
| peripheral blood samples | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| 026 | #939 |
| lactococcus lactis | #939 |
| 13 years | #940 |
| potential confounders | #940 |
| dermatophagoides | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| environmental effects | #952 |
| identification genes | #952 |
| 454 pyrosequencing | #953 |
| genotyped | #954 |
| polymorphisms | #954 |
| asthma exercise | #954 |
| solids | #954 |
| 1120 | #954 |
| human life | #955 |
| infections child | #957 |
| children countries | #959 |
| fever | #959 |
| exposures | #961 |
| domestic | #961 |
| rhinitis asthma | #961 |
| disease asthma | #964 |
| nasal secretions | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| gondii infection | #976 |
| orphan receptor | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| xinafoate | #981 |
| 682 | #981 |
| receptor gene | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| c3h hej | #991 |
| 068 | #991 |
| pasteurization | #991 |
| hercules | #992 |
| asthma humans | #992 |
| function development | #992 |
| design methods | #994 |
| sectional | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| rural population | #1006 |
| maternally | #1006 |
| ppg | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| phytohemagglutinin | #1017 |
| 039 | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| 096 | #1033 |
| genomewide association | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| dairying | #1039 |
| breastmilk | #1039 |
| nod1 | #1042 |
| milieu | #1046 |
| disease children | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| hobbies | #1059 |
| infant gut | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| rural | #1066 |
| predictor | #1066 |
| skin sensitization | #1068 |
| 8 12 | #1068 |
| gnp | #1069 |
| moraxella | #1070 |
| central europe | #1070 |
| margarine | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| cross sectional study | #1077 |
| large population | #1077 |
| west east | #1079 |
| box transcription | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| study areas | #1083 |
| cells tregs | #1083 |
| allergic airway | #1083 |
| children prevalence | #1086 |
| sufferers | #1086 |
| maternal asthma | #1089 |
| lca | #1090 |
| gene expression data | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| nationality | #1096 |
| proteins polymorphism | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| enfants | #1103 |
| forkhead | #1103 |
| conjunctivitis | #1104 |
| studies evidence | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| weight risk | #1116 |
| 248 | #1116 |
| risk gene | #1117 |
| characteristically | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| il12b | #1127 |
| sscp analysis | #1127 |
| lung function decline | #1127 |
| based clustering | #1128 |
| taxonomies | #1130 |
| endotoxins | #1130 |
| age birth | #1132 |
| expiratory flow | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| pet ownership | #1144 |
| log2 | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| pediatric asthma | #1146 |
| patients severe asthma | #1146 |
| skewness | #1152 |
| 837 | #1152 |
| humans respiratory | #1153 |
| regions china | #1154 |
| environmental tobacco | #1154 |
| disease cohort | #1156 |
| dust mite | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| 027 | #1165 |
| anti ige | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| contre | #1184 |
| serum immunoglobulin | #1184 |
| food allergens | #1186 |
| new paradigm | #1189 |
| asthma bronchodilator | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| sedentary lifestyle | #1211 |
| fungi humans | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| food hypersensitivity | #1218 |
| risk children | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| age menarche | #1236 |
| gene variants | #1236 |
| th1 th2 | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| small children | #1243 |
| antitrypsin | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| early years | #1252 |
| pertussis | #1252 |
| airway hyperreactivity | #1253 |
| food items | #1253 |
| peripheral blood leukocytes | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| pollution indoor | #1281 |
| fev1 forced | #1281 |
| children exposure | #1282 |
| shannon | #1284 |
| infections risk | #1284 |
| immunomodulating | #1289 |
| diseases occupational | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| explain | #1303 |
| topic polymorphism | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| factor development | #1312 |
| lymphocytes regulatory | #1312 |
| industrially | #1314 |
| th1 cytokines | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| harmonization | #1322 |
| epidemiological survey | #1322 |
| cell numbers | #1322 |
| objective investigate | #1327 |
| neuraminic | #1329 |
| cleaning | #1329 |
| concerted | #1330 |
| lrti | #1330 |
| prevalence rural | #1331 |
| zusammenfassung | #1331 |
| respiratory allergy | #1332 |
| gambia | #1332 |
| sponsorship | #1335 |
| induced sputum | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| expired | #1353 |
| oxide feno | #1353 |
| irf1 | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| 16 18 | #1358 |
| reduction risk | #1358 |
| asthmatics | #1359 |
| science foundation | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| 279 | #1366 |
| france germany | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| common forms | #1383 |
| total ige | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| risk developing | #1404 |
| q21 | #1404 |
| severe atopic | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| baseline followup | #1417 |
| sige | #1417 |
| bronchodilators | #1418 |
| immune mechanisms | #1418 |
| microbial | #1419 |
| hapmap | #1421 |
| il13 | #1421 |
| longitudinal cohort | #1422 |
| bronchitis | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| timepoint | #1433 |
| asthmatic | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| centres | #1444 |
| inflammatory pathways | #1444 |
| studies europe | #1445 |
| overweight | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| agricultural workers | #1460 |
| asthma clinical | #1460 |
| infancy | #1461 |
| unique opportunity | #1461 |
| immunizations | #1463 |
| barcelona | #1464 |
| 706 | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| recognition receptors | #1470 |
| surveys questionnaires | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| leur | #1474 |
| operating characteristics | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| 1 levels | #1478 |
| innate immune responses | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| strongest predictor | #1494 |
| peptidases | #1494 |
| populationbased cohort | #1504 |
| flexural | #1505 |
| ionomycin | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| bacterial composition | #1514 |
| sulphur dioxide | #1514 |
| ergosterol | #1515 |
| epidemiological data | #1517 |
| moderate asthma | #1517 |
| living environment | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| pollution levels | #1524 |
| rôle | #1524 |
| hladq | #1527 |
| 153 | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| underlying mechanisms | #1536 |
| jia | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| licheniformis | #1584 |
| children risk | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| 775 | #1603 |
| development progression | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| erythrocyte membranes | #1612 |
| neuropeptide | #1612 |
| cells1 | #1613 |
| peak expiratory | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| ige antibodies | #1624 |
| cells th2 | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| gata3 | #1641 |
| newborn infants | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| style male | #1653 |
| population based study | #1653 |
| topic surveys | #1653 |
| card | #1655 |
| microbial diversity | #1656 |
| 034 | #1656 |
| traffic volume | #1656 |
| smoke exposure | #1657 |
| northern europe | #1661 |
| cells transcription | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| epidemiologic evidence | #1688 |
| cheese | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| innate immune | #1694 |
| obesity risk | #1694 |
| early introduction | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| gene interaction | #1704 |
| phenotyping | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| house dust mite | #1718 |
| mere | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| asthma control | #1733 |
| gabon | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| factors children | #1746 |
| cytokine genes | #1746 |
| 5 7 | #1748 |
| helminth parasites | #1749 |
| inverse relationship | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| masks | #1756 |
| male polymorphism | #1756 |
| gstm1 gstt1 | #1760 |
| fivefold | #1760 |
| refugees | #1761 |
| chronic airway | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| cells airway | #1778 |
| soot | #1778 |
| helminth infections | #1779 |
| peptidoglycan | #1782 |
| cd4cd25 | #1782 |
| occupational exposure | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| key feature | #1801 |
| 054 | #1801 |
| helminths | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| treg cells | #1812 |
| single nucleotide receptors | #1812 |
| feno | #1817 |
| censoring | #1821 |
| protein 3 | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| signal transducer | #1828 |
| asthma morbidity | #1828 |
| respiratory illnesses | #1831 |
| 112 | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| regulatory cells | #1843 |
| il4 | #1843 |
| heterogeneous disease | #1843 |
| fetal growth | #1845 |
| otus | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| unraveling | #1886 |
| diseases lung | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| population level | #1901 |
| interleukin5 | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| experimental models | #1932 |
| basics | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| juvenile idiopathic | #1946 |
| percentiles | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| moisture | #1959 |
| raised | #1959 |
| blood eosinophil | #1960 |
| immune mediated | #1960 |
| invading | #1960 |
| asthmatic subjects | #1960 |
| child female | #1966 |
| lps stimulation | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| agriculture | #2000 |
| descriptions | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| diary | #2020 |
| children data | #2020 |
| regulation genetic | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| bovine milk | #2038 |
| chymase | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| early childhood | #2075 |
| bronchial epithelial cells | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| abstracts | #2098 |
| clinical phenotypes | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| 19th century | #2103 |
| male maternal | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| reduced levels | #2111 |
| bacterial colonization | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| alternata | #2118 |
| prevalence children | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| exhalation | #2145 |
| animals child | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| immune modulation | #2157 |
| schoolchildren | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| stat6 | #2178 |
| west | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| communicable | #2213 |
| 146 | #2213 |
| lung epithelial cells | #2215 |
| indoor outdoor | #2215 |
| onset disease | #2220 |
| early development | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| diesel exhaust | #2242 |
| 12th | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| spirometric | #2247 |
| bacteria fungi | #2247 |
| immune regulation | #2248 |
| whooping | #2249 |
| preventive | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| specific immunoglobulin | #2259 |
| 108 | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| commensals | #2282 |
| cla | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| 064 | #2338 |
| methodsthe | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| prrs | #2353 |
| 922 | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| immunologically | #2386 |
| expiratory | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| bronchodilator agents | #2405 |
| diaries | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| disease review | #2468 |
| vitamin intake | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| children adolescent | #2508 |
| cytokines humans | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| interleukin13 | #2525 |
| airway responsiveness | #2525 |
| tolllike receptor | #2525 |
| 239 | #2527 |
| common cold | #2528 |
| style | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| inverse | #2553 |
| switzerland | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| suggested | #2584 |
| activator | #2584 |
| myristate | #2585 |
| disease development | #2586 |
| sectional survey | #2586 |
| human microbiome | #2588 |
| ω3 | #2590 |
| 030 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| prenatal exposure | #2638 |
| illness surveys | #2638 |
| translate | #2640 |
| molecular patterns | #2641 |
| imputation | #2641 |
| cb | #2643 |
| 141 | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| virus diseases | #2657 |
| exhaled nitric oxide | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| confounder | #2678 |
| gene expression levels | #2678 |
| urgently | #2684 |
| girls boys | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| 061 | #2699 |
| host factors | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| prenatally | #2721 |
| il23r | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| risk allele | #2739 |
| worldwide | #2739 |
| reaction polymorphism | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| effects air | #2770 |
| species level | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| gstm1 | #2787 |
| messenger receptors | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| deubiquitinating | #2878 |
| tobacco smoke | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| virtually | #2928 |
| male gender | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| 804 | #2985 |
| patients asthma | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| year age | #2996 |
| critical period | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| doubt | #3065 |
| epigenetic mechanisms | #3065 |
| tlrs | #3068 |
| findings studies | #3069 |
| dna extraction | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| preschool children | #3087 |
| adaptive immune responses | #3087 |
| rapid increase | #3089 |
| rural area | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| health surveys | #3257 |
| beds | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| missing data | #3261 |
| systemic inflammation | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| corynebacterium | #3318 |
| surveys humans | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| acid receptor | #3354 |
| noncommunicable diseases | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| turn | #3409 |
| protecting | #3409 |
| alternaria alternata | #3418 |
| gg | #3421 |
| tlr | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| factors smoking | #3445 |
| air pollution | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| airflow limitation | #3468 |
| 049 | #3468 |
| cytokine responses | #3469 |
| th2 cytokine | #3470 |
| omega6 | #3470 |
| rye | #3480 |
| humans linkage | #3484 |
| 089 | #3484 |
| 043 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| postal | #3507 |
| evidences | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| respiratory mucosa | #3525 |
| 032 | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| toxoplasma | #3686 |
| disequilibrium male | #3686 |
| genetic control | #3686 |
| 046 | #3688 |
| adult blood | #3691 |
| monocytogenes | #3691 |
| host immune | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| 456 | #3704 |
| gloves | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| desorption ionization | #3735 |
| genetic gene | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| glutathione transferase | #3755 |
| 094 | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| positive bacteria | #3766 |
| regressions | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| utero | #3873 |
| immunoglobulin | #3873 |
| berlin | #3876 |
| respiratory diseases | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 319 | #3920 |
| 368 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| asthma exacerbations | #3957 |
| progeny | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| variation humans | #4026 |
| messenger reverse | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| ema | #4036 |
| environments | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| chronic disease | #4118 |
| 052 | #4118 |
| ethnically | #4120 |
| effects exposure | #4120 |
| children 2 | #4126 |
| positional | #4136 |
| 087 | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| husbandry | #4180 |
| mrna expression | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| participated | #4256 |
| indoor environments | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| cx3cl1 | #4318 |
| ephedrine | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| age 12 | #4405 |
| fluticasone | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| cephalometry | #4418 |
| exposure levels | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| secondary prevention | #4449 |
| dr3 | #4449 |
| receptors protein | #4451 |
| chances | #4457 |
| rash | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| respiratory viruses | #4468 |
| increased prevalence | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| prevalence risk factors | #4499 |
| severe asthma | #4499 |
| culture techniques | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| ahr | #4583 |
| population prevalence | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| adaptor protein | #4600 |
| haplotypes humans | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| 624 | #4896 |
| occupations | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| airway disease | #4975 |
| 322 | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| epidemiology | #5018 |
| laser desorption | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| hormonal | #5091 |
| held | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| unexposed | #5099 |
| habits | #5099 |
| genomewide significance | #5100 |
| 097 | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| fingerprinting | #5191 |
| lung epithelial | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| isotype | #5247 |
| bronchopulmonary | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| gene expression | #5348 |
| suppressive | #5348 |
| immunology | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| challenge | #5476 |
| epidemiologic | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| 373 | #5496 |
| cytokines disease | #5496 |
| floor | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| methacholine | #5602 |
| figures | #5602 |
| 258 | #5610 |
| 2nd | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| 081 | #5668 |
| protein coupled | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| offspring | #5704 |
| 134 | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| comprehensive | #5824 |
| humans immunity | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| encourage | #5930 |
| adjust | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| questionnaire survey | #5947 |
| investigate association | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| 367 | #6008 |
| patients symptoms | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| adult population | #6032 |
| obese children | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| unselected | #6082 |
| ors | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| conferred | #6117 |
| recruiting | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| populations | #6233 |
| genuine | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| administration inhalation | #6246 |
| prematurity | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| infrequent | #6326 |
| allele frequencies | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| adverse health | #6475 |
| lower respiratory | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| sleep disturbance | #6507 |
| gst | #6507 |
| 238 | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| 283 | #6602 |
| disease onset | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| haplotypes | #6732 |
| impulse | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| elucidated | #6846 |
| growing | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| pathogenic bacteria | #6972 |
| lung | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| type 1 diabetes | #7111 |
| linoleic acid | #7111 |
| triggering | #7114 |
| serum total | #7117 |
| breath tests | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| agents anti | #7184 |
| likewise | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| beta1 | #7244 |
| influences | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| herpesviridae | #7299 |
| urbanization | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| alps | #7515 |
| spp | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| diseases animals | #7613 |
| overt | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| prenatal | #7684 |
| peanut | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| prevalence incidence | #7950 |
| lockdown | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| regarded | #8119 |
| determinants | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| nineteen | #8357 |
| genera | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| syncytial | #8462 |
| anhydride | #8462 |
| contrasting | #8463 |
| minor | #8478 |
| similarities | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| ears | #8884 |
| burden disease | #8884 |
| cesarean | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| popularity | #9269 |
| multivariate analyses | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| haplotype | #9306 |
| allele frequency | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| responders | #9364 |
| olds | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| crude | #9672 |
| dietary supplements | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| directly | #9772 |
| publications | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| cluster | #9849 |
| 102 | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| 1991 | #9964 |
| bacterial infections | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| 4 months | #10169 |
| exclusions | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| interleukin12 | #10361 |
| factorial | #10361 |
| 142 | #10364 |
| centrally | #10386 |
| concepts | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| regulation humans | #10776 |
| female gastrointestinal | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| serology | #11092 |
| low birth | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| 222 | #11824 |
| gram negative | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| inflammatory cytokine | #12469 |
| european | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| scarce | #12583 |
| 17 years | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| elevated levels | #12943 |
| infants | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| annually | #13056 |
| 52 | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| suffer | #13086 |
| future | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| feces | #15556 |
| 003 | #15556 |
| dysregulation | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 09 | #16918 |
| 91 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| earlier | #17361 |
| drug therapy | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| candidate | #18807 |
| sum | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| 1997 | #18843 |
| basis | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| mouse model | #19415 |
| trait loci | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| 1998 | #19855 |
| inbred balb mice | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| baseline | #19977 |
| context | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
Relatório de execução | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| Conhecido por Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| Conhecido por International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| Conhecido por Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| Conhecido por Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| Conhecido por Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| Conhecido por Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| Conhecido por Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| Conhecido por European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| Conhecido por Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| Conhecido por East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| Conhecido por International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| Conhecido por Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| Conhecido por Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
Pessoas importantes para Atopic Dermatitis
Principais kols do mundo
Selecione uma frase de pesquisa atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:Impacto especializado
Conceitos para os quaisErika RM von Mutiustem influência direta:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:Kol Impact
Conceitos relacionados ao trabalho de outros autores para os quaisfor which Erika RM von Mutius tem influência:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
Este é o seu perfil? Reivindique seu perfil Copiar URL Incorporar link para o seu perfil |